BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332-354. [PMID: 7601427 DOI: 10.1002/hep.1840220145] [Cited by in Crossref: 439] [Cited by in F6Publishing: 438] [Article Influence: 16.3] [Reference Citation Analysis]
Number Citing Articles
1 Arora NK, Ganguly S, Mathur P, Ahuja A, Patwari A. Upper gastrointestinal bleeding: etiology and management. Indian J Pediatr 2002;69:155-68. [PMID: 11929033 DOI: 10.1007/BF02859378] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
2 Liu CH, Hsu SJ, Liang CC, Tsai FC, Lin JW, Liu CJ, Yang PM, Lai MY, Chen PJ, Chen JH, Kao JH, Chen DS. Esophageal varices: noninvasive diagnosis with duplex Doppler US in patients with compensated cirrhosis. Radiology. 2008;248:132-139. [PMID: 18483230 DOI: 10.1148/radiol.2481071257] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
3 Shao XD, Qi XS, Guo XZ. Esophageal Stent for Refractory Variceal Bleeding: A Systemic Review and Meta-Analysis. Biomed Res Int. 2016;2016:4054513. [PMID: 27517043 DOI: 10.1155/2016/4054513] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
4 Thalheimer U, Triantos C, Goulis J, Burroughs AK. Management of varices in cirrhosis. Expert Opin Pharmacother 2011;12:721-35. [PMID: 21269241 DOI: 10.1517/14656566.2011.537258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
5 Hassoun Z, Pomier-Layrargues G. The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension. Eur J Gastroenterol Hepatol. 2004;16:1-4. [PMID: 15095845 DOI: 10.1097/00042737-200401000-00001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
6 Khan S, Tudur Smith C, Williamson P, Sutton R. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev. 2006;CD000553. [PMID: 17054131 DOI: 10.1002/14651858.CD000553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Iversen P, Keiding S, Mouridsen K, Ott P, Vilstrup H. Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow. Clin Gastroenterol Hepatol 2011;9:1001-3. [PMID: 21806953 DOI: 10.1016/j.cgh.2011.07.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
8 Okamoto E, Amano Y, Fukuhara H, Furuta K, Miyake T, Sato S, Ishihara S, Kinoshita Y. Does gastroesophageal reflux have an influence on bleeding from esophageal varices? J Gastroenterol. 2008;43:803-808. [PMID: 18958550 DOI: 10.1007/s00535-008-2232-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
9 Stiegmann GV. Evolution of endoscopic therapy for esophageal varices. Surg Endosc 2006;20 Suppl 2:S467-70. [PMID: 16544066 DOI: 10.1007/s00464-006-0003-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
10 Hou MC, Lin HC, Liu TT, Kuo BI, Lee FY, Chang FY, Lee SD. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology. 2004;39:746-753. [PMID: 14999693 DOI: 10.1002/hep.20126] [Cited by in Crossref: 274] [Cited by in F6Publishing: 204] [Article Influence: 15.2] [Reference Citation Analysis]
11 Ling SC, Walters T, McKiernan PJ, Schwarz KB, Garcia-Tsao G, Shneider BL. Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr. 2011;52:254-261. [PMID: 21336158 DOI: 10.1097/mpg.0b013e318205993a] [Cited by in Crossref: 74] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
12 Eroglu Y, Emerick KM, Whitingon PF, Alonso EM. Octreotide Therapy for Control of Acute Gastrointestinal Bleeding in Children: . Journal of Pediatric Gastroenterology and Nutrition 2004;38:41-7. [DOI: 10.1097/00005176-200401000-00011] [Cited by in Crossref: 66] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
13 Triantos CK, Burroughs AK. Prevention of the development of varices and first portal hypertensive bleeding episode. Best Pract Res Clin Gastroenterol. 2007;21:31-42. [PMID: 17223495 DOI: 10.1016/j.bpg.2006.06.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
14 Asge Technology Committee. Conway JD, Adler DG, Diehl DL, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Mamula P, Rodriguez SA, Tierney WM. Endoscopic hemostatic devices. Gastrointest Endosc. 2009;69:987-996. [PMID: 19410037 DOI: 10.1016/j.gie.2008.12.251] [Cited by in Crossref: 81] [Cited by in F6Publishing: 47] [Article Influence: 6.2] [Reference Citation Analysis]
15 Bosch J. Prevention of Variceal Rebleeding: Endoscopes, Drugs, and More. Hepatology 2000;32:660-2. [DOI: 10.1053/jhep.2000.16663] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
16 D’Amico G, Politi F, Morabito A, D’Antoni A, Guerrera D, Giannuoli G, Traina M, Vizzini G, Pasta L, Pagliaro L. Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial. Hepatology. 1998;28:1206-1214. [PMID: 9794903 DOI: 10.1002/hep.510280507] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 1.9] [Reference Citation Analysis]
17 Seo YS, Park SY, Kim MY, Kim JH, Park JY, Yim HJ, Jang BK, Kim HS, Hahn T, Kim BI, Heo J, An H, Tak WY, Baik SK, Han KH, Hwang JS, Park SH, Cho M, Um SH. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology. 2014;60:954-963. [PMID: 24415445 DOI: 10.1002/hep.27006] [Cited by in Crossref: 105] [Cited by in F6Publishing: 73] [Article Influence: 13.1] [Reference Citation Analysis]
18 Merli M, Salerno F, Riggio O, de Franchis R, Fiaccadori F, Meddi P, Primignani M, Pedretti G, Maggi A, Capocaccia L, Lovaria A, Ugolotti U, Salvatori F, Bezzi M, Rossi P. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.). Hepatology. 1998;27:48-53. [PMID: 9425916 DOI: 10.1002/hep.510270109] [Cited by in Crossref: 125] [Cited by in F6Publishing: 111] [Article Influence: 5.2] [Reference Citation Analysis]
19 Imperiale TF, Klein RW, Chalasani N. Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding. Hepatology. 2007;45:870-878. [PMID: 17393528 DOI: 10.1002/hep.21605] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
20 Wright AS, Rikkers LF. Current management of portal hypertension. J Gastrointest Surg. 2005;9:992-1005. [PMID: 16137597 DOI: 10.1016/j.gassur.2004.09.028] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
21 Caronna R, Bezzi M, Schiratti M, Cardi M, Prezioso G, Benedetti M, Papini F, Mangioni S, Martino G, Chirletti P. Severe bleeding from esophageal varices resistant to endoscopic treatment in a non cirrhotic patient with portal hypertension. World J Emerg Surg 2008;3:24. [PMID: 18644135 DOI: 10.1186/1749-7922-3-24] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Junquera F, López-Talavera JC, Mearin F, Saperas E, Videla S, Armengol JR, Esteban R, Malagelada JR. Somatostatin plus isosorbide 5-mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled clinical trial. Gut 2000;46:127-32. [PMID: 10601068 DOI: 10.1136/gut.46.1.127] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
23 Corbett C, Mangat K, Olliff S, Tripathi D. The role of Transjugular Intrahepatic Portosystemic Stent-Shunt (TIPSS) in the management of variceal hemorrhage. Liver Int. 2012;32:1493-1504. [PMID: 22928699 DOI: 10.1111/j.1478-3231.2012.02861.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
24 Wolff M, Hirner A. Current state of portosystemic shunt surgery. Langenbecks Arch Surg 2003;388:141-9. [PMID: 12942328 DOI: 10.1007/s00423-003-0367-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
25 Kim H, Choi D, Gwak GY, Lee JH, Lee SJ, Kim SH, Lee JY, Park Y, Chang I, Lim HK. High-risk esophageal varices in patients treated with locoregional therapies for hepatocellular carcinoma: evaluation with regular follow-up liver CT. Dig Dis Sci. 2009;54:2247-2252. [PMID: 19051016 DOI: 10.1007/s10620-008-0606-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
26 Martins Santos MM, Correia LP, Rodrigues RA, Lenz Tolentino LH, Ferrari AP, Della Libera E. Splenic artery embolization and infarction after cyanoacrylate injection for esophageal varices. Gastrointest Endosc. 2007;65:1088-1090. [PMID: 17451707 DOI: 10.1016/j.gie.2006.10.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
27 Schepke M, Werner E, Biecker E, Schiedermaier P, Heller J, Neef M, Stoffel-Wagner B, Hofer U, Caselmann WH, Sauerbruch T. Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology 2001;121:389-95. [PMID: 11487548 DOI: 10.1053/gast.2001.26295] [Cited by in Crossref: 101] [Cited by in F6Publishing: 83] [Article Influence: 4.8] [Reference Citation Analysis]
28 Grewal P, Martin P. Care of the cirrhotic patient. Clin Liver Dis 2009;13:331-40. [PMID: 19442922 DOI: 10.1016/j.cld.2009.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
29 Boyer TD, Haskal ZJ;  American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386-400. [PMID: 15660434 DOI: 10.1002/hep.20559] [Cited by in Crossref: 286] [Cited by in F6Publishing: 226] [Article Influence: 16.8] [Reference Citation Analysis]
30 Dagher L, Patch D, Burroughs A. Drug treatment for bleeding oesophageal varices. Best Practice & Research Clinical Gastroenterology 2000;14:365-90. [DOI: 10.1053/bega.2000.0085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
31 Lopez-mendez E, Avila-escobedo L. Pregnancy and portal hypertension a pathology view of physiologic changes. Annals of Hepatology 2006;5:219-23. [DOI: 10.1016/s1665-2681(19)32016-2] [Cited by in Crossref: 12] [Article Influence: 0.8] [Reference Citation Analysis]
32 Boyer TD. NATURAL HISTORY OF PORTAL HYPERTENSION. Clinics in Liver Disease 1997;1:31-44. [DOI: 10.1016/s1089-3261(05)70253-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
33 Bittencourt PL, Farias AQ, Strauss E, Mattos AA; Pannel of the 1st Brazilian Consensus of Variceal Bleeding, Brazilian Society of Hepatology. Variceal bleeding: consensus meeting report from the Brazilian Society of Hepatology. Arq Gastroenterol. 2010;47:202-216. [PMID: 20721469 DOI: 10.1590/s0004-28032010000200017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
34 Palaniappan SK, Than NN, Thein AW, Moe S, van Mourik I. Interventions for preventing and managing advanced liver disease in cystic fibrosis. Cochrane Database Syst Rev 2017;8:CD012056. [PMID: 28850173 DOI: 10.1002/14651858.CD012056.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Rössle M, Grandt D, Kowdley K, Mccaughan G, Trautwein C. Early transjugular intrahepatic portosystemic shunt in patients with cirrhosis and variceal bleeding. Hepatology 2010;52:1847-50. [DOI: 10.1002/hep.23982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
36 Johnson M, Rajendran S, Balachandar TG, Kannan D, Jeswanth S, Ravichandran P, Surendran R. Transabdominal modified devascularization procedure with or without esophageal stapler transection--an operation adequate for effective control of a variceal bleed. Is esophageal stapler transection necessary? World J Surg. 2006;30:1507-1518; discussion 1519. [PMID: 16865318 DOI: 10.1007/s00268-005-0754-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
37 Gado A, Ebeid B, Abdelmohsen A, Axon A. Predictors of mortality in patients with acute upper gastrointestinal hemorrhage who underwent endoscopy and confirmed to have variceal hemorrhage. Alexandria Journal of Medicine 2015;51:295-304. [DOI: 10.1016/j.ajme.2014.08.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
38 Seewald S, Ang TL, Imazu H, Naga M, Omar S, Groth S, Seitz U, Zhong Y, Thonke F, Soehendra N. A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos). Gastrointestinal Endoscopy 2008;68:447-54. [DOI: 10.1016/j.gie.2008.02.050] [Cited by in Crossref: 106] [Cited by in F6Publishing: 83] [Article Influence: 7.6] [Reference Citation Analysis]
39 Nagaoki Y, Aikata H, Daijyo K, Teraoka Y, Honda F, Nakamura Y, Hatooka M, Morio K, Fujino H, Nakahara T, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Chayama K. Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus-related cirrhosis. Hepatol Res 2018;48:264-74. [PMID: 29114970 DOI: 10.1111/hepr.12996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
40 Madonia S, D'amico G, Traina M, Gatto G, Virdone R, Salamone N, Licata A, Tarantino I, Pagliaro L. Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: a long-term cohort study. Digestive and Liver Disease 2000;32:782-91. [DOI: 10.1016/s1590-8658(00)80356-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
41 D'Amico G, Pagliaro L, Pietrosi G, Tarantino I. Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients. Cochrane Database Syst Rev. 2010;CD002233. [PMID: 20238318 DOI: 10.1002/14651858.cd002233.pub2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
42 Abraldes JG, Bosch J. The treatment of acute variceal bleeding. J Clin Gastroenterol. 2007;41 Suppl 3:S312-S317. [PMID: 17975482 DOI: 10.1097/mcg.0b013e318150d3dd] [Cited by in Crossref: 35] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
43 Pfisterer N, Riedl F, Pachofszky T, Gschwantler M, König K, Schuster B, Mandorfer M, Gessl I, Illiasch C, Fuchs EM, Unger L, Dolak W, Maieron A, Kramer L, Madl C, Trauner M, Reiberger T. Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study. Liver Int 2019;39:290-8. [PMID: 30248224 DOI: 10.1111/liv.13971] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
44 Mamori S, Searashi Y, Matsushima M, Hashimoto K, Uetake S, Matsudaira H, Ito S, Nakajima H, Tajiri H. Serum type IV collagen level is predictive for esophageal varices in patients with severe alcoholic disease. World J Gastroenterol 2008; 14(13): 2044-2048 [PMID: 18395904 DOI: 10.3748/wjg.14.2044] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
45 Maufa F, Al-Kawas FH. Role of self-expandable metal stents in acute variceal bleeding. Int J Hepatol. 2012;2012:418369. [PMID: 22928113 DOI: 10.1155/2012/418369] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
46 Avgerinos A, Armonis A, Manolakopoulos S, Rekoumis G, Argirakis G, Viazis N, Vlachogiannakos J, Adamopoulos A, Kanaghinis T, Raptis SA. Endoscopic sclerotherapy plus propranolol versus propranolol alone in the primary prevention of bleeding in high risk cirrhotic patients with esophageal varices: A prospective multicenter randomized trial. Gastrointestinal Endoscopy 2000;51:652-8. [DOI: 10.1067/mge.2000.105983] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
47 Kamath PS, Mckusick MA. 8 Transjugular intrahepatic portosystemic shunts (TIPS). Baillière's Clinical Gastroenterology 1997;11:327-49. [DOI: 10.1016/s0950-3528(97)90043-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
48 Grieser C, Denecke T, Steffen IG, Avgenaki M, Fröhling V, Mogl M, Schnapauff D, Lehmkuhl L, Stelter L, Streitparth F. Multidetector computed tomography for preoperative assessment of hepatic vasculature and prediction of splenic artery steal syndrome in patients with liver cirrhosis before transplantation. Eur Radiol. 2010;20:108-117. [PMID: 19662418 DOI: 10.1007/s00330-009-1535-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
49 Bosch J, Garcia-tsao G. Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: And the winner is…. Hepatology 2009;50:674-7. [DOI: 10.1002/hep.23164] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
50 Chuah YY, Hsu PI, Tsai WL, Yu HC, Tsay FW, Chen WC, Lin KH, Lee YY, Wang HM. Short-term vasoactive agent treatment driven by physicians' preference in acute esophageal variceal bleeding in a tertiary center. PeerJ 2019;7:e7913. [PMID: 31720102 DOI: 10.7717/peerj.7913] [Reference Citation Analysis]
51 Brensing KA, Raab P, Textor J, Görich J, Schiedermaier P, Strunk H, Paar D, Schepke M, Sudhop T, Spengler U, Schild H, Sauerbruch T. Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis: . European Journal of Gastroenterology & Hepatology 2002;14:723-31. [DOI: 10.1097/00042737-200207000-00003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
52 Lee HY, Lee HJ, Lee SM, Kim JH, Kweon SW, Lee BS, Kim NJ. A prospective randomized controlled clinical trial comparing the effects of somatostatin and vasopressin for control of acute variceal bleeding in the patients with liver cirrhosis. Korean J Intern Med 2003;18:161-6. [PMID: 14619385 DOI: 10.3904/kjim.2003.18.3.161] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
53 Iannitti DA, Henderson JM. The role of surgery in the treatment of portal hypertension. Clin Liver Dis. 1997;1:99-114, xi. [PMID: 15562671 DOI: 10.1016/s1089-3261(05)70258-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Huang YT, Cheng YR, Lin HC, Hou MC, Lee SD, Hong CY. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats. Dig Dis Sci 1998;43:358-64. [PMID: 9512131 DOI: 10.1023/a:1018866608377] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
55 Piyachaturawat P, Siramolpiwat S, Sonsiri K, Tangkijvanich P, Treeprasertsuk S. Changes in transient elastography in early cirrhotic patients after receiving nonselective B-blocker for primary variceal bleeding prophylaxis: Three-month follow up. JGH Open 2018;2:172-7. [PMID: 30483585 DOI: 10.1002/jgh3.12063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Al-Ali J, Pawlowska M, Coss A, Svarta S, Byrne M, Enns R. Endoscopic management of gastric variceal bleeding with cyanoacrylate glue injection: safety and efficacy in a Canadian population. Can J Gastroenterol. 2010;24:593-596. [PMID: 21037987 DOI: 10.1155/2010/276273] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
57 Helmy A, Hayes PC. Review article: current endoscopic therapeutic options in the management of variceal bleeding. Aliment Pharmacol Ther. 2001;15:575-594. [PMID: 11328251 DOI: 10.1046/j.1365-2036.2001.00950.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
58 Reddy SI, Grace ND. Liver imaging. A hepatologist's perspective. Clin Liver Dis 2002;6:297-310, ix. [PMID: 11933595 DOI: 10.1016/s1089-3261(03)00077-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
59 Groszmann RJ, Garcia-tsao G. Endoscopic variceal banding vs. pharmacological therapy for the prevention of recurrent variceal hemorrhage: What makes the difference? Gastroenterology 2002;123:1388-91. [DOI: 10.1053/gast.2002.36364] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
60 Huang HC, Wang SS, Chang CC, Lee FY, Lin HC, Hou MC, Teng TH, Chen YC, Lee SD. Evolution of portal-systemic collateral vasopressin response in endotoxemic portal hypertensive rats. Shock. 2009;32:503-508. [PMID: 19295490 DOI: 10.1097/shk.0b013e3181a1bf86] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
61 Austin AS, Mahida YR, Clarke D, Ryder SD, Freeman JG. A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis: THALIDOMIDE IN PORTAL HYPERTENSION. Alimentary Pharmacology & Therapeutics 2004;19:79-88. [DOI: 10.1046/j.1365-2036.2003.01809.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
62 Pfisterer N, Unger LW, Reiberger T. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis. World J Hepatol 2021; 13(7): 731-746 [PMID: 34367495 DOI: 10.4254/wjh.v13.i7.731] [Reference Citation Analysis]
63 An Y, Xu X, Ren T, Tong Z, Romeiro FG, Mancuso A, Guo X, Qi X. Adherence to Non-Selective Beta Blockers for Prevention of Variceal Bleeding in Cirrhotic Patients. Int J Gen Med 2021;14:6713-24. [PMID: 34675632 DOI: 10.2147/IJGM.S326192] [Reference Citation Analysis]
64 Lee SW, Lee TY, Chang CS. Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage. Dig Dis Sci. 2009;54:1128-1134. [PMID: 19051032 DOI: 10.1007/s10620-008-0454-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
65 Almeida JR, Trevisan L, Guerrazzi F, Mesquita MA, Ferraz JG, Montes CG, Kisilwzky NH, Yamanaka A, Soares EC. Bleeding duodenal varices successfully treated with TIPS. Dig Dis Sci. 2006;51:1738-1741. [PMID: 16967309 DOI: 10.1007/s10620-006-9335-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
66 Garcia N, Sanyal AJ. Portal hypertension. Clin Liver Dis. 2001;5:509-540. [PMID: 11385974 DOI: 10.1016/s1089-3261(05)70176-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Chapin CA, Bass LM. Cirrhosis and Portal Hypertension in the Pediatric Population. Clin Liver Dis. 2018;22:735-752. [PMID: 30266160 DOI: 10.1016/j.cld.2018.06.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
68 Chitapanarux T, Ritdamrongthum P, Leerapun A, Pisespongsa P, Thongsawat S. Three-day versus five-day somatostatin infusion combination with endoscopic variceal ligation in the prevention of early rebleeding following acute variceal hemorrhage: A randomized controlled trial: Early variceal rebleeding, somatostatin. Hepatol Res 2015;45:1276-82. [DOI: 10.1111/hepr.12503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
69 Furuta A, Isoda H, Ohno T, Ono A, Yamashita R, Arizono S, Kido A, Sakashita N, Togashi K. Left Gastric Vein Visualization with Hepatopetal Flow Information in Healthy Subjects Using Non-Contrast-Enhanced Magnetic Resonance Angiography with Balanced Steady-State Free-Precession Sequence and Time-Spatial Labeling Inversion Pulse. Korean J Radiol 2018;19:32-9. [PMID: 29353997 DOI: 10.3348/kjr.2018.19.1.32] [Reference Citation Analysis]
70 Huang HC, Wang SS, Chan CC, Lee FY, Chang FY, Lin HC, Hou MC, Tai CC, Lai IN, Lee SD. Chronic inhibition of nitric oxide increases the collateral vascular responsiveness to vasopressin in portal hypertensive rats. J Hepatol. 2004;40:234-238. [PMID: 14739093 DOI: 10.1016/j.jhep.2003.10.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
71 Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310-335. [PMID: 27786365 DOI: 10.1002/hep.28906] [Cited by in Crossref: 713] [Cited by in F6Publishing: 537] [Article Influence: 118.8] [Reference Citation Analysis]
72 Rahimi RS, Guntipalli P, Rockey DC. Worldwide practices for pharmacologic therapy in esophageal variceal hemorrhage. Scand J Gastroenterol 2014;49:131-7. [PMID: 24295524 DOI: 10.3109/00365521.2013.850736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
73 Nelson DB, Bosco JJ, Curtis WD, Faigel DO, Kelsey PB, Leung JW, Mills MR, Smith P, Tarnasky PR, VanDam J, Wassef WY. ASGE technology status evaluation report. Injection needles. February 1999. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 1999;50:928-31. [PMID: 10644194 DOI: 10.1016/s0016-5107(99)70198-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Barange K, Péron JM, Imani K, Otal P, Payen JL, Rousseau H, Pascal JP, Joffre F, Vinel JP. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology. 1999;30:1139-1143. [PMID: 10534333 DOI: 10.1002/hep.510300523] [Cited by in Crossref: 130] [Cited by in F6Publishing: 99] [Article Influence: 5.7] [Reference Citation Analysis]
75 Villanueva C, Ortiz J, Sàbat M, Gallego A, Torras X, Soriano G, Sáinz S, Boadas J, Cussó X, Guarner C, Balanzó J. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology 1999;30:384-9. [PMID: 10421644 DOI: 10.1002/hep.510300222] [Cited by in Crossref: 76] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
76 Iavarone M, Primignani M, Vavassori S, Sangiovanni A, La Mura V, Romeo R, Colombo M. Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib. United European Gastroenterol J 2016;4:363-70. [PMID: 27403302 DOI: 10.1177/2050640615615041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
77 Efrati O, Barak A, Modan-Moses D, Augarten A, Vilozni D, Katznelson D, Szeinberg A, Yahav J, Bujanover Y. Liver cirrhosis and portal hypertension in cystic fibrosis. Eur J Gastroenterol Hepatol 2003;15:1073-8. [PMID: 14501614 DOI: 10.1097/00042737-200310000-00002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
78 Maslekar S, Toh EW, Adair R, Bate JP, Botterill I. Systematic review of anorectal varices. Colorectal Dis. 2013;15:e702-e710. [PMID: 24020839 DOI: 10.1111/codi.12417] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
79 Yao XX, Jiang SL, Yao DM. Current research of hepatic cirrhosis in China. World J Gastroenterol 2005; 11(5): 617-622 [PMID: 15655809 DOI: 10.3748/wjg.v11.i5.617] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
80 Roberts SK, Dudley FJ. Management of haematemesis and melaena. Med J Aust 1997;166:549-53. [PMID: 9196489 DOI: 10.5694/j.1326-5377.1997.tb123249.x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
81 Dittrich S, Mattos AA, Mattos AZ, Alves AV, Araújo FB. [Relationship between portal pressure gradient and ascites in cirrhotic patients]. Arq Gastroenterol. 2010;47:174-177. [PMID: 20721463 DOI: 10.1590/S0004-28032010000200011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Kumar KN, Sarkar K. Interfacial Rheological Properties of Contrast Microbubble Targestar P as a Function of Ambient Pressure. Ultrasound in Medicine & Biology 2016;42:1010-7. [DOI: 10.1016/j.ultrasmedbio.2015.11.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
83 Fevery J, Nevens F. Oesophageal varices: assessment of the risk of bleeding and mortality. J Gastroenterol Hepatol. 2000;15:842-848. [PMID: 11022823 DOI: 10.1046/j.1440-1746.2000.02211.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
84 Dong MH, Saab S. Complications of cirrhosis. Dis Mon 2008;54:445-56. [PMID: 18570914 DOI: 10.1016/j.disamonth.2008.03.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
85 Bandi JC, García-Pagán JC, Escorsell A, François E, Moitinho E, Rodés J, Bosch J. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology 1998;28:677-82. [PMID: 9731558 DOI: 10.1002/hep.510280312] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
86 Patch D, Burroughs A. 7 Advances in drug therapy for acute variceal haemorrhage. Baillière's Clinical Gastroenterology 1997;11:311-26. [DOI: 10.1016/s0950-3528(97)90042-7] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
87 Sharma P, Rakela J. Management of pre-liver transplantation patient?Part 2. Liver Transpl 2005;11:249-60. [DOI: 10.1002/lt.20379] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
88 Garcia-pagan JC. Non-selective beta-blockers in the prevention of first variceal bleeding. Is there any definite alternative? Journal of Hepatology 2002;37:393-5. [DOI: 10.1016/s0168-8278(02)00244-1] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
89 Wongcharatrawee S, Groszmann RJ. Diagnosing portal hypertension. Best Practice & Research Clinical Gastroenterology 2000;14:881-94. [DOI: 10.1053/bega.2000.0136] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
90 Conn HO. PORTAL HYPERTENSION, VARICES, AND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS. Clinics in Liver Disease 2000;4:133-50. [DOI: 10.1016/s1089-3261(05)70100-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
91 Huang H, Lee F, Huo T. Major adverse events, pretransplant assessment and outcome prediction. Journal of Gastroenterology and Hepatology 2009;24:1716-24. [DOI: 10.1111/j.1440-1746.2009.06025.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
92 Hou MC, Lin HC, Lee FY, Chang FY, Lee SD. Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: comparison of sclerotherapy and ligation. J Hepatol. 2000;32:202-208. [PMID: 10707859 DOI: 10.1016/s0168-8278(00)80064-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
93 Goldis A, Goldis R, Chirila TV. Biomaterials in Gastroenterology: A Critical Overview. Medicina (Kaunas) 2019;55:E734. [PMID: 31726779 DOI: 10.3390/medicina55110734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
94 Stumm MM, D'orazio D, Sumanovski LT, Martin P, Reichen J, Sieber CC. Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats: Nitric oxide synthesis in rats. Liver 2002;22:441-50. [DOI: 10.1034/j.1600-0676.2002.01653.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
95 Shashidhar H, Langhans N, Grand RJ. Propranolol in Prevention of Portal Hypertensive Hemorrhage in Children: A Pilot Study: . Journal of Pediatric Gastroenterology & Nutrition 1999;29:12-7. [DOI: 10.1097/00005176-199907000-00007] [Cited by in Crossref: 68] [Cited by in F6Publishing: 48] [Article Influence: 3.0] [Reference Citation Analysis]
96 Bosch J, Abraldes JG, Groszmann R. Current management of portal hypertension. J Hepatol. 2003;38 Suppl 1:S54-S68. [PMID: 12591186 DOI: 10.1016/s0168-8278(02)00430-0] [Cited by in Crossref: 182] [Cited by in F6Publishing: 38] [Article Influence: 9.6] [Reference Citation Analysis]
97 Qu EZ, Zhang YC, Li ZY, Liu Y, Wang JR. Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis. J Ultrasound Med. 2014;33:1971-1977. [PMID: 25336484 DOI: 10.7863/ultra.33.11.1971] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
98 Chen WC, Lo GH, Tsai WL, Hsu PI, Lin CK, Lai KH. Emergency endoscopic variceal ligation versus somatostatin for acute esophageal variceal bleeding. J Chin Med Assoc. 2006;69:60-67. [PMID: 16570572 DOI: 10.1016/s1726-4901(09)70115-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
99 Ryan BM, Stockbrugger RW, Ryan JM. TIPS for gastric varices. Gut 2003;52:772; author reply 772. [PMID: 12692074 DOI: 10.1136/gut.52.5.772] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
100 Lo GH. Management of acute esophageal variceal hemorrhage. Kaohsiung J Med Sci. 2010;26:55-67. [PMID: 20123593 DOI: 10.1016/s1607-551x(10)70009-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
101 Comar KM, Sanyal AJ. Portal hypertensive bleeding. Gastroenterology Clinics of North America 2003;32:1079-105. [DOI: 10.1016/s0889-8553(03)00099-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
102 Gluud LL, Morgan MY; Cochrane Hepato-Biliary Group. Endoscopic therapy and beta-blockers for secondary prevention in adults with cirrhosis and oesophageal varices. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
103 Hung TH, Tseng CW, Tsai CC, Lay CJ, Tsai CC. A fourfold increase of oesophageal variceal bleeding in cirrhotic patients with a history of oesophageal variceal bleeding. Singapore Med J 2016;57:511-3. [PMID: 26768323 DOI: 10.11622/smedj.2015177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
104 Albillos A, Perez-Paramo M, Cacho G, Iborra J, Calleja JL, Millán I, Muñoz J, Rossi I, Escartín P. Accuracy of portal and forearm blood flow measurements in the assessment of the portal pressure response to propranolol. J Hepatol 1997;27:496-504. [PMID: 9314127 DOI: 10.1016/s0168-8278(97)80354-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
105 Moitinho E, Escorsell A, Bandi JC, Salmerón JM, García-Pagán JC, Rodés J, Bosch J. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999;117:626-631. [PMID: 10464138 DOI: 10.1016/s0016-5085(99)70455-5] [Cited by in Crossref: 319] [Cited by in F6Publishing: 91] [Article Influence: 13.9] [Reference Citation Analysis]
106 Ramires RP, Zils CK, Mattos AA. [Sclerotherapy versus somatostatin in the treatment of upper digestive hemorrhage caused by rupture of esophageal varices]. Arq Gastroenterol 2000;37:148-54. [PMID: 11236267 DOI: 10.1590/s0004-28032000000300002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
107 Valeriani E, Di Nisio M, Riva N, Cohen O, Porreca E, Senzolo M, De Gottardi A, Magaz M, Garcia-Pagan JC, Ageno W. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Thromb Haemost 2021;121:867-76. [PMID: 33525037 DOI: 10.1055/s-0040-1722192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
108 Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ. Randomized trial of emergency endoscopic sclerotherapy versus emergency portacaval shunt for acutely bleeding esophageal varices in cirrhosis. J Am Coll Surg. 2009;209:25-40. [PMID: 19651060 DOI: 10.1016/j.jamcollsurg.2009.02.059] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
109 Puente A, Hernández-gea V, Graupera I, Roque M, Colomo A, Poca M, Aracil C, Gich I, Guarner C, Villanueva C. Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review. Liver Int 2014;34:823-33. [DOI: 10.1111/liv.12452] [Cited by in Crossref: 68] [Cited by in F6Publishing: 47] [Article Influence: 8.5] [Reference Citation Analysis]
110 Bosch J, García-pagán JC. Prevention of variceal rebleeding. The Lancet 2003;361:952-4. [DOI: 10.1016/s0140-6736(03)12778-x] [Cited by in Crossref: 272] [Cited by in F6Publishing: 77] [Article Influence: 14.3] [Reference Citation Analysis]
111 Moreno L, Angeles Mart�nez-cuesta MA, Piqu� JM, Bosch J, Esplugues JV. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 1996;354:474-80. [DOI: 10.1007/bf00168439] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
112 Sarin SK, Kumar A, Angus PW, Baijal SS, Chawla YK, Dhiman RK, Janaka de Silva H, Hamid S, Hirota S, Hou MC. Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int. 2008;2:429-439. [PMID: 19669318 DOI: 10.1007/s12072-008-9096-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
113 Koya Y, Shibata M, Watanabe T, Kumei S, Miyagawa K, Oe S, Honma Y, Kume K, Yoshikawa I, Harada M. Influence of gastroesophageal flap valve on esophageal variceal bleeding in patients with liver cirrhosis. Dig Endosc 2021;33:100-9. [PMID: 32274835 DOI: 10.1111/den.13685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Kochhar GS, Navaneethan U, Hartman J, Mari Parungao J, Lopez R, Gupta R, Kapoor B, Mehta P, Sanaka M. Comparative study of endoscopy vs. transjugular intrahepatic portosystemic shunt in the management of gastric variceal bleeding. Gastroenterol Rep (Oxf) 2015;3:75-82. [PMID: 25673803 DOI: 10.1093/gastro/gou095] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
115 Sun HY, Lee JM, Han JK, Choi BI. Usefulness of MR elastography for predicting esophageal varices in cirrhotic patients. J Magn Reson Imaging. 2014;39:559-566. [PMID: 24115368 DOI: 10.1002/jmri.24186] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
116 Agha A, Abdulhadi MM, Marenco S, Bella A, Alsaudi D, El-Haddad A, Inferrera S, Savarino V, Giannini EG. Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol 2011;17:307-11. [PMID: 21912056 DOI: 10.4103/1319-3767.84483] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
117 Pratt D, Epstein S. Recent Advances in Critical Care Gastroenterology. Am J Respir Crit Care Med 2000;161:1417-20. [DOI: 10.1164/ajrccm.161.5.16159] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
118 Abraldes JG, Angermayr B, Bosch J. The management of portal hypertension. Clin Liver Dis 2005;9:685-713, vii. [PMID: 16207571 DOI: 10.1016/j.cld.2005.08.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
119 Fernández-Varo G, Oró D, Cable EE, Reichenbach V, Carvajal S, de la Presa BG, Wiśniewski K, Ginés P, Harris G, Jiménez W. Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats. Hepatology 2016;63:207-16. [PMID: 26403564 DOI: 10.1002/hep.28250] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
120 D'Amico M, Berzigotti A, Garcia-Pagan JC. Refractory acute variceal bleeding: what to do next?Clin Liver Dis. 2010;14:297-305. [PMID: 20682236 DOI: 10.1016/j.cld.2010.03.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
121 Kovacs TO, Jensen DM. Recent advances in the endoscopic diagnosis and therapy of upper gastrointestinal, small intestinal, and colonic bleeding. Med Clin North Am. 2002;86:1319-1356. [PMID: 12510456 DOI: 10.1016/s0025-7125(02)00079-2] [Cited by in Crossref: 50] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
122 Satapathy SK, Sanyal AJ. Nonendoscopic management strategies for acute esophagogastric variceal bleeding. Gastroenterol Clin North Am 2014;43:819-33. [PMID: 25440928 DOI: 10.1016/j.gtc.2014.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
123 Rössle M. Early TIPS in patients with cirrhosis and variceal bleeding. Nat Rev Gastroenterol Hepatol 2010;7:536-8. [DOI: 10.1038/nrgastro.2010.147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
124 Park WG, Yeh RW, Triadafilopoulos G. Injection therapies for variceal bleeding disorders of the GI tract. Gastrointest Endosc. 2008;67:313-323. [PMID: 18226695 DOI: 10.1016/j.gie.2007.09.052] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
125 Kisilevzky NH. TIPS para o controle das complicações da hipertensão portal: eficácia, fatores prognósticos associados e variações técnicas. Radiol Bras 2006;39:385-95. [DOI: 10.1590/s0100-39842006000600004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
126 Gralnek IM, Jensen DM, Kovacs TO, Jutabha R, Machicado GA, Gornbein J, King J, Cheng S, Jensen ME. The economic impact of esophageal variceal hemorrhage: Cost-effectiveness implications of endoscopic therapy. Hepatology 1999;29:44-50. [DOI: 10.1002/hep.510290141] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
127 Ede CJ, Nikolova D, Brand M. Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis. Cochrane Database Syst Rev 2018;8:CD011717. [PMID: 30073663 DOI: 10.1002/14651858.CD011717.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
128 Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ. Emergency portacaval shunt versus rescue portacaval shunt in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis--part 3. J Gastrointest Surg 2010;14:1782-95. [PMID: 20658205 DOI: 10.1007/s11605-010-1279-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
129 Aoyama T, Oka S, Aikata H, Igawa A, Nakano M, Naeshiro N, Yoshida S, Tanaka S, Chayama K. Major predictors of portal hypertensive enteropathy in patients with liver cirrhosis. J Gastroenterol Hepatol. 2015;30:124-130. [PMID: 24988903 DOI: 10.1111/jgh.12658] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
130 Rubenstein JH, Inadomi JM. Empiric beta-blockers for the prophylaxis of variceal hemorrhage: cost effective or clinically applicable? Hepatology. 2003;37:249-252. [PMID: 12540773 DOI: 10.1053/jhep.2003.50089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
131 Voros D, Polydorou A, Polymeneas G, Vassiliou I, Melemeni A, Chondrogiannis K, Arapoglou V, Fragulidis GP. Long-term results with the modified Sugiura procedure for the management of variceal bleeding: standing the test of time in the treatment of bleeding esophageal varices. World J Surg. 2012;36:659-666. [PMID: 22270986 DOI: 10.1007/s00268-011-1418-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
132 García-pagán JC, Bosch J. 5 Pharmacological prevention of variceal bleeding. New developments. Baillière's Clinical Gastroenterology 1997;11:271-87. [DOI: 10.1016/s0950-3528(97)90040-3] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
133 Escorsell À, Bañares R, García-pagán JC, Gilabert R, Moitinho E, Piqueras B, Bru C, Echenagusia A, Granados A, Bosch J. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: A randomized controlled trial: TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: A randomized controlled trial. Hepatology 2002;35:385-92. [DOI: 10.1053/jhep.2002.30418] [Cited by in Crossref: 162] [Cited by in F6Publishing: 116] [Article Influence: 8.5] [Reference Citation Analysis]
134 Trivedi HD, Tapper EB. Interventions to improve physical function and prevent adverse events in cirrhosis. Gastroenterol Rep (Oxf) 2018;6:13-20. [PMID: 29479438 DOI: 10.1093/gastro/gox042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
135 Zaman A, Chalasani N. Bleeding caused by portal hypertension. Gastroenterol Clin North Am 2005;34:623-42. [PMID: 16303574 DOI: 10.1016/j.gtc.2005.08.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
136 Yan X, Shao R, Wang Y, Mao X, Lei J, Zhang L, Zheng J, Liu A, Zhao H, Gao F, Wang J, Li P, Yao S, Xu M, Xu J, Liu D, Mi Y, Gong X, Ye J, Deng M, Dang T, Ji J, Shao C, Liu C, Gu Y, Wu Y, Wang F, Teng G, Li X, Qi X, Ju S, Qi X. Functional magnetic resonance imaging-based assessment of terlipressin vs. octreotide on renal function in cirrhotic patients with acute variceal bleeding (CHESS1903): study protocol of a multicenter randomized controlled trial. Ann Transl Med 2019;7:586. [PMID: 31807567 DOI: 10.21037/atm.2019.09.141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
137 Habib A, Sanyal AJ. Acute Variceal Hemorrhage. Gastrointest Endosc Clin N Am. 2007;17:223-252. [PMID: 17556146 DOI: 10.1016/j.giec.2007.03.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
138 Stanley AJ, Therapondos G, Helmy A, Hayes PC. Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis. Journal of Hepatology 1999;30:479-84. [DOI: 10.1016/s0168-8278(99)80108-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
139 D'amico G, Pagliaro L, Pietrosi G, Tarantino I, D'amico G. Emergency sclerotherapy versus medical interventions for bleeding oesophageal varices in cirrhotic patients. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd002233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
140 Rössle M. When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done? Immediate control of bleeding by TIPS? Langenbecks Arch Surg 2003;388:155-62. [PMID: 12728322 DOI: 10.1007/s00423-003-0372-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
141 Paik CN, Kim SW, Lee IS, Park JM, Cho YK, Choi MG, Chung IS. The therapeutic effect of cyanoacrylate on gastric variceal bleeding and factors related to clinical outcome. J Clin Gastroenterol. 2008;42:916-922. [PMID: 18645533 DOI: 10.1097/MCG.0b013e31811edcd1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
142 Takehara T, Sakamori R. Remaining challenges for the noninvasive diagnosis of esophageal varices in liver cirrhosis. Esophagus 2020;17:19-24. [PMID: 31620917 DOI: 10.1007/s10388-019-00699-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
143 Romero G, Kravetz D, Argonz J, Vulcano C, Suarez A, Fassio E, Dominguez N, Bosco A, Muñoz A, Salgado P, Terg R. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Aliment Pharmacol Ther 2006;24:601-11. [PMID: 16827811 DOI: 10.1111/j.1365-2036.2006.03007.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
144 Moitinho E, Planas R, Banares R, Albillos A, Ruiz-del-Arbol L, Galvez C, Bosch J; Vaticeal Bleeding Study Group. Multicenter randomized controlled trial comparing different schedules of sonatostatin in the treatment of acute variceal bleeding. J Hepatol. 2001;35:712-718. [PMID: 11738097 DOI: 10.1016/S0168-8278(01)00206-9] [Cited by in Crossref: 104] [Cited by in F6Publishing: 11] [Article Influence: 5.2] [Reference Citation Analysis]
145 Oida T, Mimatsu K, Kano H, Kawasaki A, Kuboi Y, Fukino N, Amano S. Post-gastrectomy spleen enlargement and esophageal varices: Distal vs total gastrectomy. World J Gastroenterol 2010; 16(22): 2801-2805 [PMID: 20533601 DOI: 10.3748/wjg.v16.i22.2801] [Reference Citation Analysis]
146 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W;  Practice Guidelines Committee of the American Association for the Study of Liver Diseases;  Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922-938. [PMID: 17879356 DOI: 10.1002/hep.21907] [Cited by in Crossref: 1135] [Cited by in F6Publishing: 905] [Article Influence: 75.7] [Reference Citation Analysis]
147 Ong JP, Sands M, Younossi ZM. Transjugular intrahepatic portosystemic shunts (TIPS): a decade later. J Clin Gastroenterol. 2000;30:14-28. [PMID: 10636206 DOI: 10.1097/00004836-200001000-00005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
148 de Mattos ÂZ, Terra C, Farias AQ, Bittencourt PL, Alliance of Brazilian Centers for Cirrhosis Care–the ABC Group. Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies. World J Gastrointest Endosc 2021; 13(12): 628-637 [DOI: 10.4253/wjge.v13.i12.628] [Reference Citation Analysis]
149 Ingrand P, Gournay J, Bernard P, Oberti F, Bernard-Chabert B, Pauwels A, Renard P, Bartoli E, Cadranel JF, Barbare JC, Ingrand I, Beauchant M, Portale TCFPLL. Management of digestive bleeding related to portal hypertension in cirrhotic patients: A French multicenter cross-sectional practice survey. World J Gastroenterol 2006; 12(48): 7810-7814 [PMID: 17203525 DOI: 10.3748/wjg.v12.i48.7810] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
150 Luketic VA, Sanyal AJ. Esophageal varices. I. Clinical presentation, medical therapy, and endoscopic therapy. Gastroenterol Clin North Am. 2000;29:337-385. [PMID: 10836186 DOI: 10.1016/s0889-8553(05)70119-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
151 Boregowda U, Umapathy C, Halim N, Desai M, Nanjappa A, Arekapudi S, Theethira T, Wong H, Roytman M, Saligram S. Update on the management of gastrointestinal varices. World J Gastrointest Pharmacol Ther 2019; 10(1): 1-21 [PMID: 30697445 DOI: 10.4292/wjgpt.v10.i1.1] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
152 Escorsell A, Ruiz del Arbol L, Planas R, Albillos A, Bañares R, Calès P, Pateron D, Bernard B, Vinel JP, Bosch J. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST study. Hepatology 2000;32:471-6. [PMID: 10960437 DOI: 10.1053/jhep.2000.16601] [Cited by in F6Publishing: 79] [Reference Citation Analysis]
153 Marrero JA, Scheiman JM. Prevention of recurrent variceal bleeding: As easy as A.P.C.? Gastrointestinal Endoscopy 2002;56:600-3. [DOI: 10.1016/s0016-5107(02)70462-8] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
154 Krige JE, Kotze UK, Bornman PC, Shaw JM, Klipin M. Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices. Ann Surg. 2006;244:764-770. [PMID: 17060770 DOI: 10.1097/01.sla.0000231704.45005.4e] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
155 Bruha R, Vitek L, Petrtyl J, Lenicek M, Urbanek P, Zelenka J, Jachymova M, Svestka T, Kalab M, Dousa M, Marecek Z. Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes. Scandinavian Journal of Gastroenterology 2009;41:1454-63. [DOI: 10.1080/00365520600780403] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
156 Avgerinos A, Armonis A, Manolakopoulos S, Poulianos G, Rekoumis G, Sgourou A, Gouma P, Raptis S. Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study. J Hepatol. 1997;26:1034-1041. [PMID: 9186834 DOI: 10.1016/s0168-8278(97)80112-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
157 Rockey DC. Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices. Curr Gastroenterol Rep 2006;8:7-13. [PMID: 16510029 DOI: 10.1007/s11894-006-0058-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
158 Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut. 2000;46 Suppl 3-4:III1-III15. [PMID: 10862604 DOI: 10.1136/gut.46.suppl_3.iii1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 71] [Article Influence: 1.7] [Reference Citation Analysis]
159 Khan S, Tudur Smith C, Williamson P, Sutton R. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev. 2006;CD000553. [PMID: 17054131 DOI: 10.1002/14651858.cd000553.pub2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
160 Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, Brú C, Rodés J, Bruix J. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62-67. [PMID: 9862851 DOI: 10.1002/hep.510290145] [Cited by in Crossref: 765] [Cited by in F6Publishing: 742] [Article Influence: 33.3] [Reference Citation Analysis]
161 Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut. 2000;47:288-295. [PMID: 10896924 DOI: 10.1136/gut.47.2.288] [Cited by in Crossref: 322] [Cited by in F6Publishing: 218] [Article Influence: 14.6] [Reference Citation Analysis]
162 Wiest R, Tsai M, Groszmann RJ. Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats. Gastroenterology 2001;120:975-83. [DOI: 10.1053/gast.2001.22529] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 3.2] [Reference Citation Analysis]
163 Brett BT, Hayes PC, Jalan R. Primary prophylaxis of variceal bleeding in cirrhosis: . European Journal of Gastroenterology & Hepatology 2001;13:349-58. [DOI: 10.1097/00042737-200104000-00008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
164 Thalheimer U, Mela M, Patch D, Burroughs AK. Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence. Gut. 2004;53:143-148. [PMID: 14684589 DOI: 10.1136/gut.53.1.143] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
165 Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial. Lancet. 1997;350:1495-1499. [PMID: 9388396 DOI: 10.1016/s0140-6736(97)05099-x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
166 Tripathi D, Stanley AJ, Hayes PC, Patch D, Millson C, Mehrzad H, Austin A, Ferguson JW, Olliff SP, Hudson M, Christie JM;  Clinical Services and Standards Committee of the British Society of Gastroenterology. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64:1680-1704. [PMID: 25887380 DOI: 10.1136/gutjnl-2015-309262] [Cited by in Crossref: 260] [Cited by in F6Publishing: 197] [Article Influence: 37.1] [Reference Citation Analysis]
167 Drastich P, Lata J, Petrtyl J, Bruha R, Prochazka V, Vanasek T, Zdenek P, Skibova J, Hucl T, Spicak J. Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding. Annals of Hepatology 2011;10:142-9. [DOI: 10.1016/s1665-2681(19)31562-5] [Cited by in Crossref: 15] [Article Influence: 1.4] [Reference Citation Analysis]
168 Joshi NG, Stanley AJ. Update on the management of variceal bleeding. Scott Med J 2005;50:5-10. [PMID: 15792378 DOI: 10.1177/003693300505000102] [Reference Citation Analysis]
169 Al-Busafi SA, Ghali P, Wong P, Deschenes M. Endoscopic management of portal hypertension. Int J Hepatol 2012;2012:747095. [PMID: 22830037 DOI: 10.1155/2012/747095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
170 Nelson DB, Barkun AN, Block KP, Burdick J, Ginsberg GG, Greenwald DA, Kelsey PB, Nakao NL, Slivka A, Smith P, Vakil N. Endoscopic hemostatic devices. Gastrointestinal Endoscopy 2001;54:833-40. [DOI: 10.1016/s0016-5107(01)70088-0] [Cited by in Crossref: 25] [Article Influence: 1.2] [Reference Citation Analysis]
171 Ryckman FC, Alonso MH. CAUSES AND MANAGEMENT OF PORTAL HYPERTENSION IN THE PEDIATRIC POPULATION. Clinics in Liver Disease 2001;5:789-818. [DOI: 10.1016/s1089-3261(05)70192-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
172 Toubia N, Sanyal AJ. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2008;92:551-574, viii. [PMID: 18387376 DOI: 10.1016/j.mcna.2007.12.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
173 Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jiménez E, Marrero JM, Buceta E, Sánchez J, Castellot A. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40:793-801. [PMID: 15382120 DOI: 10.1002/hep.1840400408] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
174 Schneider AW, Kalk JF, Klein CP. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology. 1999;29:334-339. [PMID: 9918907 DOI: 10.1002/hep.510290203] [Cited by in Crossref: 140] [Cited by in F6Publishing: 127] [Article Influence: 6.1] [Reference Citation Analysis]
175 Tsochatzis EA, Triantos CK, Garcovich M, Burroughs AK. Primary Prevention of Variceal Hemorrhage. Curr Gastroenterol Rep 2011;13:3-9. [DOI: 10.1007/s11894-010-0160-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
176 Ponziani FR, De Stefano V, Gasbarrini A. Viral cirrhosis: an overview of haemostatic alterations and clinical consequences. Mediterr J Hematol Infect Dis 2009;1:e2009033. [PMID: 21415961 DOI: 10.4084/MJHID.2009.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
177 Jalanko H, Pakarinen M. Combined liver and kidney transplantation in children. Pediatr Nephrol. 2014;29:805-14; quiz 812. [PMID: 23644898 DOI: 10.1007/s00467-013-2487-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
178 Carreiro G, Moreira ADL, Murad FF, Azevedo F, Coelho HSM. TIPS - anastomose portossistêmica intra-hepática transjugular. Revisão. Arq Gastroenterol 2001;38:69-80. [DOI: 10.1590/s0004-28032001000100013] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
179 Castro Filho EC, Perazzo H, Guimaraes RAP, Machado L, Fernandes FF, Perez RM. Reliability and safety of transnasal compared to conventional endoscopy for detecting oesophageal varices in cirrhotic patients. Liver Int. 2018;38:1418-1426. [PMID: 29323459 DOI: 10.1111/liv.13692] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
180 Livingstone AS, Koniaris LG, Perez EA, Alvarez N, Levi JU, Hutson DG. 507 Warren-Zeppa distal splenorenal shunts: a 34-year experience. Ann Surg 2006;243:884-92; discussion 892-4. [PMID: 16772792 DOI: 10.1097/01.sla.0000219681.08312.87] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
181 Lowe RC, Grace ND. Pharmacologic therapy for portal hyper-tension. Curr Gastroenterol Rep. 2001;3:24-29. [PMID: 11177691 DOI: 10.1007/s11894-001-0037-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
182 Stanley AJ, Bouchier IA, Hayes PC. Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients. Gut 1998;42:283-7. [PMID: 9536956 DOI: 10.1136/gut.42.2.283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
183 Sharma S, Gurakar A, Jabbour N. Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1. Dig Dis Sci 2008;53:1757-73. [PMID: 17990105 DOI: 10.1007/s10620-007-0079-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
184 Moller S, Brinch K, Henriksen JH, Becker U. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis. J Hepatol. 1997;26:1026-1033. [PMID: 9186833 DOI: 10.1016/S0168-8278(97)80111-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
185 Krige J, Bornman P. Endoscopic Therapy in the Management of Esophageal Varices: Injection Sclerotherapy and Variceal Ligation. Surgery of the Liver, Biliary Tract and Pancreas. Elsevier; 2007. pp. 1579-93. [DOI: 10.1016/b978-1-4160-3256-4.50112-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
186 Albillos A, Calleja JL, Ruiz-del-arbol L. Sclerotherapy in acute variceal bleeding. Gastrointestinal Endoscopy 1999;49:140-1. [DOI: 10.1016/s0016-5107(99)70471-2] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
187 Escorsell A, Bosch J. Self-expandable metal stents in the treatment of acute esophageal variceal bleeding. Gastroenterol Res Pract. 2011;2011:910986. [PMID: 22013436 DOI: 10.1155/2011/910986] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
188 Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World J Gastroenterol 2020; 26(40): 6111-6140 [PMID: 33177789 DOI: 10.3748/wjg.v26.i40.6111] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
189 Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology. 2002;122:1620-1630. [PMID: 12016427 DOI: 10.1053/gast.2002.33419] [Cited by in Crossref: 152] [Cited by in F6Publishing: 127] [Article Influence: 7.6] [Reference Citation Analysis]
190 Northup PG, Abecassis MM, Englesbe MJ, Emond JC, Lee VD, Stukenborg GJ, Tong L, Berg CL; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl 2009;15:148-62. [PMID: 19177435 DOI: 10.1002/lt.21671] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
191 Kim YD, Cheon GJ, Kim MY, Suk KT, Baik SK, Kim DJ. Changes in the clinical outcomes of variceal bleeding in cirrhotic patients: a 10-year experience in gangwon province, South Korea. Gut Liver 2012;6:476-81. [PMID: 23170153 DOI: 10.5009/gnl.2012.6.4.476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
192 Sun L, Zhou H, Gu L, Jiang C, Liu Y, Xu Q. Effects of surgical procedures on the occurrence and development of postoperative portal vein thrombosis in patients with cirrhosis complicated by portal hypertension. Int J Surg 2015;16:31-5. [PMID: 25701619 DOI: 10.1016/j.ijsu.2015.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
193 Payancé A, Bissonnette J, Roux O, Elkrief L, Gault N, Francoz C, Nekachtali O, Soubrane O, Lebrec D, Valla D, Durand F, Rautou P. Lack of clinical or haemodynamic rebound after abrupt interruption of beta-blockers in patients with cirrhosis. Aliment Pharmacol Ther 2016;43:966-73. [DOI: 10.1111/apt.13577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
194 Luketic VA. MANAGEMENT OF PORTAL HYPERTENSION AFTER VARICEAL HEMORRHAGE. Clinics in Liver Disease 2001;5:677-707. [DOI: 10.1016/s1089-3261(05)70188-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
195 Molleston JP. Variceal bleeding in children. J Pediatr Gastroenterol Nutr. 2003;37:538-545. [PMID: 14581793 DOI: 10.1097/00005176-200311000-00006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
196 Rajapaksha IG, Gunarathne LS, Angus PW, Herath CB. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options. J Clin Med 2021;10:702. [PMID: 33670126 DOI: 10.3390/jcm10040702] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
197 Thabut D, Bernard-Chabert B. Management of acute bleeding from portal hypertension. Best Pract Res Clin Gastroenterol. 2007;21:19-29. [PMID: 17223494 DOI: 10.1016/j.bpg.2006.07.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
198 de Souza AR, La Mura V, Berzigotti A, García-Pagán JC, Abraldes JG, Bosch J. Prognosis of acute variceal bleeding: Is being on beta-blockers an aggravating factor? A short-term survival analysis. Hepatology 2015;62:1840-6. [PMID: 26340692 DOI: 10.1002/hep.28151] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
199 Li L, Yu C, Li Y. Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis. Can J Gastroenterol. 2011;25:147-155. [PMID: 21499579 DOI: 10.1155/2011/346705] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
200 Daves SM. The Liver and Vascular Surgery. Semin Cardiothorac Vasc Anesth 2000;4:275-88. [DOI: 10.1177/108925320000400409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
201 Helmy A, Al Kahtani K, Al Fadda M. Updates in the pathogenesis, diagnosis and management of ectopic varices. Hepatol Int. 2008;2:322-334. [PMID: 19669261 DOI: 10.1007/s12072-008-9074-1] [Cited by in Crossref: 103] [Cited by in F6Publishing: 66] [Article Influence: 7.4] [Reference Citation Analysis]
202 Tapper EB, Beste L, Curry M, Bonder A, Waljee A, Saini S. Suboptimal Implementation of Evidence-based Therapy for Acute Variceal Hemorrhage: A Systematic Review of Observational Studies. Clinical Gastroenterology and Hepatology 2017;15:1373-1381.e7. [DOI: 10.1016/j.cgh.2017.02.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
203 Krasko A, Deshpande K, Bonvino S. Liver failure, transplantation, and critical care. Critical Care Clinics 2003;19:155-83. [DOI: 10.1016/s0749-0704(02)00051-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
204 Luigiano C, Iabichino G, Judica A, Virgilio C, Peta V, Abenavoli L. Role of endoscopy in management of gastrointestinal complications of portal hypertension. World J Gastrointest Endosc 2015; 7(1): 1-12 [PMID: 25610530 DOI: 10.4253/wjge.v7.i1.1] [Cited by in CrossRef: 4] [Article Influence: 0.6] [Reference Citation Analysis]
205 Gawrieh S, Saeian K. Management of esophageal varices: an update from Digestive Disease Week and American Association for the Study of Liver Diseases 2003. Curr Gastroenterol Rep 2004;6:206-9. [PMID: 15128486 DOI: 10.1007/s11894-004-0008-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
206 Agarwal A, Kumar SS, Sadasivan J, Kate V. Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial. J Pharmacol Pharmacother. 2015;6:24-29. [PMID: 25709348 DOI: 10.4103/0976-500X.149139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
207 Lo GH, Chen WC, Wang HM, Lee CC. Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding. Hepatology. 2010;52:230-237. [PMID: 20578138 DOI: 10.1002/hep.23617] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
208 Chen PH, Hsieh WY, Su CW, Hou MC, Wang YP, Hsin IF, Yang TC, Liao WC, Lin HC, Lee FY, Wu JC. Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices. Gastrointest Endosc. 2018;88:230-239.e2. [PMID: 29317268 DOI: 10.1016/j.gie.2017.12.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
209 Mercado MA, Orozco H, Ramírez-Cisneros FJ, Hinojosa CA, Plata JJ, Alvarez-Tostado J. Diminished morbidity and mortality in portal hypertension surgery: relocation in the therapeutic armamentarium. J Gastrointest Surg. 2001;5:499-502. [PMID: 11986000 DOI: 10.1016/S1091-255X(01)80087-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
210 Dittrich S, Mattos AAD, Cheinquer H, Araújo FBD. Correlação entre a contagem de plaquetas no sangue e o gradiente de pressão venosa hepática em pacientes cirróticos. Arq Gastroenterol 2005;42:35-40. [DOI: 10.1590/s0004-28032005000100009] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
211 Balzer C, Lotterer E, Kleber G, Fleig WE. Transjugular intrahepatic portosystemic shunt for bleeding angiodysplasia-like lesions in portal-hypertensive colopathy. Gastroenterology 1998;115:167-72. [PMID: 9649472 DOI: 10.1016/s0016-5085(98)70378-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
212 Liu T, Lin H, Huang Y, Sun C, Hong C. Portal Hypotensive Effects of Tetrandrine and Verapamil in Portal Hypertensive Rats. Journal of Pharmacy and Pharmacology 1997;49:85-8. [DOI: 10.1111/j.2042-7158.1997.tb06757.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
213 Rivet C, Robles-Medranda C, Dumortier J, Le Gall C, Ponchon T, Lachaux A. Endoscopic treatment of gastroesophageal varices in young infants with cyanoacrylate glue: a pilot study. Gastrointest Endosc. 2009;69:1034-1038. [PMID: 19152910 DOI: 10.1016/j.gie.2008.07.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
214 Schepke M, Kleber G, Nürnberg D, Willert J, Koch L, Veltzke-Schlieker W, Hellerbrand C, Kuth J, Schanz S, Kahl S. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2004;40:65-72. [PMID: 15239087 DOI: 10.1002/hep.20284] [Cited by in Crossref: 148] [Cited by in F6Publishing: 111] [Article Influence: 8.2] [Reference Citation Analysis]
215 Chen WC, Hou MC, Lin HC, Yu KW, Lee FY, Chang FY, Lee SD. Bacteremia after endoscopic injection of N-butyl-2-cyanoacrylate for gastric variceal bleeding. Gastrointest Endosc. 2001;54:214-218. [PMID: 11474393 DOI: 10.1067/mge.2001.116566] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
216 Grünhage F, Heller J, Appenrodt B, Schmitz V, Sauerbruch T. [Medical therapy of complications in liver cirrhosis]. Internist (Berl) 2007;48:1349-57. [PMID: 17992496 DOI: 10.1007/s00108-007-1965-z] [Reference Citation Analysis]
217 Pagliaro L. Lebrec D, Poynard T, Hillon P, Benhamou J-P. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. A controlled study [N Engl J Med 1981;305:1371-1374]. J Hepatol. 2002;36:148-150. [PMID: 11830324 DOI: 10.1016/s0168-8278(01)00307-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
218 Reiberger T, Püspök A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, Dolak W, Ferlitsch A, Finkenstedt A, Graziadei I, Hametner S, Karnel F, Krones E, Maieron A, Mandorfer M, Peck-Radosavljevic M, Rainer F, Schwabl P, Stadlbauer V, Stauber R, Tilg H, Trauner M, Zoller H, Schöfl R, Fickert P. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr 2017;129:135-58. [PMID: 29063233 DOI: 10.1007/s00508-017-1262-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 12.4] [Reference Citation Analysis]
219 Jamwal KD, Maiwall R, Sharma MK, Kumar G, Sarin SK. Case Control Study of Post-endoscopic Variceal Ligation Bleeding Ulcers in Severe Liver Disease: Outcomes and Management. J Clin Transl Hepatol 2019;7:32-9. [PMID: 30944817 DOI: 10.14218/JCTH.2018.00059] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
220 Yamamoto J, Nagai M, Smith B, Tamaki S, Kubota T, Sasaki K, Ohmori T, Maeda K. Hand-assisted laparoscopic splenectomy and devascularization of the upper stomach in the management of gastric varices. World J Surg. 2006;30:1520-1525. [PMID: 16855808 DOI: 10.1007/s00268-005-0243-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
221 Zehetner J, Shamiyeh A, Wayand W, Hubmann R. Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent. Surg Endosc. 2008;22:2149-2152. [PMID: 18622540 DOI: 10.1007/s00464-008-0009-7] [Cited by in Crossref: 63] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
222 Saxena P, Lakhtakia S. Endoscopic ultrasound guided vascular access and therapy (with videos). Endosc Ultrasound. 2015;4:168-175. [PMID: 26374574 DOI: 10.4103/2303-9027.162994] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
223 Exon DJ, Sydney Chung SC. Endoscopic therapy for upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2004;18:77-98. [PMID: 15123086 DOI: 10.1016/s1521-6918(03)00102-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
224 Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, Mele MR, Testa E, Mansi C, Savarino V, Testa R. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003;52:1200-1205. [PMID: 12865282 DOI: 10.1136/gut.52.8.1200] [Cited by in Crossref: 275] [Cited by in F6Publishing: 225] [Article Influence: 14.5] [Reference Citation Analysis]
225 Escorsell A, Bandi JC, Moitinho E, Feu F, García-Pagan JC, Bosch J, Rodés J. Time profile of the haemodynamic effects of terlipressin in portal hypertension. J Hepatol. 1997;26:621-627. [PMID: 9075670 DOI: 10.1016/s0168-8278(97)80428-x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
226 Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ, Orloff SL. Liver transplantation in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis. Transplant Proc. 2010;42:4101-4108. [PMID: 21168637 DOI: 10.1016/j.transproceed.2010.09.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
227 Escorsell A, Bordas JM, del Arbol LR, Jaramillo JL, Planas R, Bañares R, Albillos A, Bosch J. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group. J Hepatol 1998;29:779-88. [PMID: 9833916 DOI: 10.1016/s0168-8278(98)80259-6] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
228 Reynaert H, Geerts A. Pharmacological rationale for the use of somatostatin and analogues in portal hypertension. Aliment Pharmacol Ther. 2003;18:375-386. [PMID: 12940922 DOI: 10.1046/j.1365-2036.2003.01657.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
229 Vlavianos P, Westaby D. Management of acute variceal haemorrhage: . European Journal of Gastroenterology & Hepatology 2001;13:335-42. [DOI: 10.1097/00042737-200104000-00006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
230 Huang YT, Cheng YR, Lin HC, Chen SM, Hong CY. Haemodynamic effects of chronic octreotide and tetrandrine administration in portal hypertensive rats. J Gastroenterol Hepatol. 1998;13:266-272. [PMID: 9570239 DOI: 10.1111/j.1440-1746.1998.01554.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
231 Sears D, Davis GL. Natural History of Hepatitis C. Transplantation of the Liver. Elsevier; 2005. pp. 129-41. [DOI: 10.1016/b978-0-7216-0118-2.50014-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
232 Singh H, Targownik LE, Ward G, Minuk GY, Bernstein CN. An assessment of endoscopic and concomitant management of acute variceal bleeding at a tertiary care centre. Can J Gastroenterol 2007;21:85-90. [PMID: 17299611 DOI: 10.1155/2007/296435] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
233 Xu XD, Dai JJ, Qian JQ, Pin X, Wang WJ. New index to predict esophageal variceal bleeding in cirrhotic patients. World J Gastroenterol 2014; 20(22): 6989-6994 [PMID: 24944493 DOI: 10.3748/wjg.v20.i22.6989] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
234 Lebrec D. Pharmacological treatment of portal hypertension: present and future. J Hepatol. 1998;28:896-907. [PMID: 9625326 DOI: 10.1016/s0168-8278(98)80241-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
235 Zhang HY, Li WB, Ye H, Xiao ZY, Peng YR, Wang J. Long-term results of the paraesophagogastric devascularization with or without esophageal transection: which is more suitable for variceal bleeding? World J Surg. 2014;38:2105-2112. [PMID: 24590450 DOI: 10.1007/s00268-014-2478-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
236 Monescillo A, Mart�nez-lagares F, Ruiz-del-arbol L, Sierra A, Guevara C, Jim�nez E, Marrero JM, Buceta E, S�nchez J, Castellot A, Pe�ate M, Cruz A, Pe�a E. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004;40:793-801. [DOI: 10.1002/hep.20386] [Cited by in Crossref: 322] [Cited by in F6Publishing: 217] [Article Influence: 17.9] [Reference Citation Analysis]
237 Fevery J, Nevens F. Treatment of acute esophageal variceal bleeding: a review. European Journal of Internal Medicine 1999;10:140-5. [DOI: 10.1016/s0953-6205(99)00048-5] [Reference Citation Analysis]
238 Huang HC, Wang SS, Lee FY, Chang CC, Chang FY, Lin HC, Hou MC, Lee SD. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition. J Gastroenterol Hepatol. 2008;23:e265-e269. [PMID: 17764528 DOI: 10.1111/j.1440-1746.2007.05122.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
239 Vadera S, Yong CWK, Gluud LL, Morgan MY. Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices. Cochrane Database Syst Rev 2019;6:CD012673. [PMID: 31220333 DOI: 10.1002/14651858.CD012673.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
240 Merkel C, Marin R, Enzo E, Donada C, Cavallarin G, Torboli P, Amodio P, Sebastianelli G, Sacerdoti D, Felder M, Mazzaro C, Beltrame P, Gatta A. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP). Lancet 1996;348:1677-81. [PMID: 8973428 DOI: 10.1016/s0140-6736(96)05406-2] [Cited by in Crossref: 98] [Cited by in F6Publishing: 11] [Article Influence: 3.9] [Reference Citation Analysis]
241 Mela M, Mancuso A, Burroughs A. Drug treatment for portal hypertension. Annals of Hepatology 2002;1:102-20. [DOI: 10.1016/s1665-2681(19)32169-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
242 Debray D, Lykavieris P, Gauthier F, Dousset B, Sardet A, Munck A, Laselve H, Bernard O. Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension. Journal of Hepatology 1999;31:77-83. [DOI: 10.1016/s0168-8278(99)80166-4] [Cited by in Crossref: 97] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
243 Bañares R, Albillos A, Rincón D, Alonso S, González M, Ruiz-del-arbol L, Salcedo M, Molinero L. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis: Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis. Hepatology 2002;35:609-15. [DOI: 10.1053/jhep.2002.31354] [Cited by in Crossref: 296] [Cited by in F6Publishing: 214] [Article Influence: 15.6] [Reference Citation Analysis]
244 Kovacs TO, Jensen DM. Upper or small bowel hemorrhage that presents as hematochezia. Techniques in Gastrointestinal Endoscopy 2001;3:206-15. [DOI: 10.1053/tgie.2001.27858] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
245 Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Interv Radiol. 2005;16:615-629. [PMID: 15872315 DOI: 10.1097/01.rvi.0000157297.91510.21] [Cited by in Crossref: 101] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
246 Bolognesi M, Sacerdoti D, Merkel C, Bombonato G, Enzo E, Gatta A. Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: comparison between acute and chronic effects. Journal of Hepatology 1997;26:305-11. [DOI: 10.1016/s0168-8278(97)80046-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
247 Gana JC, Cifuentes LI, Gattini D, Villarroel Del Pino LA, Peña A, Torres-Robles R. Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev 2019;9:CD010546. [PMID: 31550050 DOI: 10.1002/14651858.CD010546.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
248 Vieira da Rocha EC, D’Amico EA, Caldwell SH, Flores da Rocha TR, Soares E Silva CS, Dos Santos Bomfim V, Felga G, Barbosa WF, Kassab F, Polli DA. A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. Clin Gastroenterol Hepatol. 2009;7:988-993. [PMID: 19410018 DOI: 10.1016/j.cgh.2009.04.019] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
249 Zhou GP, Sun LY, Wei L, Qu W, Zeng ZG, Liu Y, Jiang YZ, Zhu ZJ. Comparision between portosystemic shunts and endoscopic therapy for prevention of variceal re-bleeding: a systematic review and meta-analysis. Chin Med J (Engl) 2019;132:1087-99. [PMID: 30913064 DOI: 10.1097/CM9.0000000000000212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
250 Viazis N, Armonis A, Vlachogiannakos J, Rekoumis G, Stefanidis G, Papadimitriou N, Manolakopoulos S, Avgerinos A. Effects of endoscopic variceal treatment on oesophageal function: a prospective, randomized study. Eur J Gastroenterol Hepatol. 2002;14:263-269. [PMID: 11953691 DOI: 10.1097/00042737-200203000-00010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
251 Golding MI, Doman DB, Goldberg HJ. Take your Pill(Cam): it might save your life. Gastrointestinal Endoscopy 2005;62:196-8. [DOI: 10.1016/s0016-5107(05)00543-2] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
252 García-pagán JC, Villanueva C, Vila MC, Albillos A, Genescà J, Ruiz-del-arbol L, planas R, Rodriguez M, Calleja JL, González A, Solà R, Balanzó J, Bosch J. Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive β-blockers. Gastroenterology 2001;121:908-14. [DOI: 10.1053/gast.2001.27993] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
253 Changela K, Ona MA, Anand S, Duddempudi S. Self-Expanding Metal Stent (SEMS): an innovative rescue therapy for refractory acute variceal bleeding. Endosc Int Open 2014;2:E244-51. [PMID: 26135101 DOI: 10.1055/s-0034-1377980] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
254 Rössle M. The transjugular intrahepatic portosystemic shunt. Journal of Hepatology 1996;25:224-31. [DOI: 10.1016/s0168-8278(96)80079-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
255 Chavalitdhamrong D, Jensen DM, Singh B, Kovacs TO, Han SH, Durazo F, Saab S, Gornbein JA. Capsule Endoscopy Is Not as Accurate as Esophagogastroduodenoscopy in Screening Cirrhotic Patients for Varices. Clinical Gastroenterology and Hepatology 2012;10:254-258.e1. [DOI: 10.1016/j.cgh.2011.11.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
256 Levy I, Binmoeller KF. EUS-guided vascular interventions. Endosc Ultrasound. 2018;7:228-235. [PMID: 30117484 DOI: 10.4103/eus.eus_32_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
257 Fallah MA, Prakash C, Edmundowicz S. Acute gastrointestinal bleeding. Med Clin North Am. 2000;84:1183-1208. [PMID: 11026924 DOI: 10.1016/s0025-7125(05)70282-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
258 McCormick PA, O’Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut. 2001;49:682-685. [PMID: 11600472 DOI: 10.1136/gut.49.5.682] [Cited by in Crossref: 153] [Cited by in F6Publishing: 129] [Article Influence: 7.3] [Reference Citation Analysis]
259 Monici LT, Meirelles-Santos JO, Soares EC, Mesquita MA, Zeitune JM, Montes CG, Almeida JR, Yamanaka A, Magna LA. Microwave coagulation versus sclerotherapy after band ligation to prevent recurrence of high risk of bleeding esophageal varices in Child-Pugh's A and B patients. J Gastroenterol 2010;45:204-10. [PMID: 19802519 DOI: 10.1007/s00535-009-0134-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
260 Sharma SK, Aggarwal R. Prediction of large esophageal varices in patients with cirrhosis of the liver using clinical, laboratory and imaging parameters. J Gastroenterol Hepatol. 2007;22:1909-1915. [PMID: 17914969 DOI: 10.1111/j.1440-1746.2006.04501.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
261 Cho H, Nagata N, Shimbo T, Sakurai T, Sekine K, Okubo H, Imbe K, Watanabe K, Mikami S, Yokoi C, Kobayakawa M, Mizokami M, Yanase M, Akiyama J, Uemura N. Recurrence and prognosis of patients emergently hospitalized for acute esophageal variceal bleeding: A long-term cohort study. Hepatol Res. 2016;46:1338-1346. [PMID: 26946225 DOI: 10.1111/hepr.12692] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
262 Loffroy R, Estivalet L, Cherblanc V, Favelier S, Pottecher P, Hamza S, Minello A, Hillon P, Thouant P, Lefevre PH, Krausé D, Cercueil JP. Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage. World J Gastroenterol 2013; 19(37): 6131-6143 [PMID: 24115809 DOI: 10.3748/wjg.v19.i37.6131] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
263 Garcia-Tsao G. The Child-Turcotte Classification: From Gestalt to Sophisticated Statistics and Back. Dig Dis Sci 2016;61:3102-4. [PMID: 27696097 DOI: 10.1007/s10620-016-4319-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
264 Tripathi D, Hayes PC. Review article: a drug therapy for the prevention of variceal haemorrhage. Aliment Pharmacol Ther. 2001;15:291-310. [PMID: 11207505 DOI: 10.1046/j.1365-2036.2001.00920.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
265 Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, Stiegmann GV, Henderson JM, de Franchis R, Wagner JL, Conn HO, Rodes J. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology. 1998;28:868-880. [PMID: 9731585 DOI: 10.1002/hep.510280339] [Cited by in Crossref: 274] [Cited by in F6Publishing: 242] [Article Influence: 11.4] [Reference Citation Analysis]
266 Ytting H, Møller S, Henrik Henriksen J, Larsen K, Bendtsen F. Prognosis in patients with cirrhosis and mild portal hypertension. Scandinavian Journal of Gastroenterology 2009;41:1446-53. [DOI: 10.1080/00365520600735720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
267 Grace ND, Bhattacharya K. PHARMACOLOGIC THERAPY OF PORTAL HYPERTENSION AND VARICEAL HEMORRHAGE. Clinics in Liver Disease 1997;1:59-75. [DOI: 10.1016/s1089-3261(05)70255-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
268 Bhogal HK, Sanyal AJ. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol. 2011;9:936-946; quiz e123. [PMID: 21699820 DOI: 10.1016/j.cgh.2011.06.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
269 Lee FY, Wang SS, Tsai MH, Huang HC, Lin HC, Lee SD. Adrenal dysfunction in portal hypertensive rats with acute hemorrhage. PLoS One 2014;9:e92093. [PMID: 24633079 DOI: 10.1371/journal.pone.0092093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
270 Saab S, Nieto JM, Lewis SK, Runyon BA; Cochrane Hepato-Biliary Group. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd004889.pub2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
271 Vaughan RB, Chin-dusting JP. Current pharmacotherapy in the management of cirrhosis: focus on the hyperdynamic circulation. Expert Opinion on Pharmacotherapy 2005;4:625-37. [DOI: 10.1517/14656566.4.5.625] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
272 Cheung J, Wong W, Zandieh I, Leung Y, Lee SS, Ramji A, Yoshida EM. Acute management and secondary prophylaxis of esophageal variceal bleeding: a western Canadian survey. Can J Gastroenterol. 2006;20:531-534. [PMID: 16955150 DOI: 10.1155/2006/203217] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
273 Zardi EM, Di Matteo FM, Pacella CM, Sanyal AJ. Invasive and non-invasive techniques for detecting portal hypertension and predicting variceal bleeding in cirrhosis: a review. Ann Med. 2014;46:8-17. [PMID: 24328372 DOI: 10.3109/07853890.2013.857831] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
274 Simonetti RG, Perricone G, Robbins HL, Battula NR, Weickert MO, Sutton R, Khan S. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis. Cochrane Database Syst Rev 2020;10:CD000553. [PMID: 33089892 DOI: 10.1002/14651858.CD000553.pub3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
275 Kravetz D. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations. J Clin Gastroenterol. 2007;41 Suppl 3:S318-S322. [PMID: 17975483 DOI: 10.1097/mcg.0b013e318157f0a7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
276 Tripathi D, Therapondos G, Lui HF, Stanley AJ, Hayes PC. Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating β-blocker, in patients with cirrhosis and portal hypertension: LOW-DOSE CARVEDILOL AND PORTAL HYPERTENSION. Alimentary Pharmacology & Therapeutics 2002;16:373-80. [DOI: 10.1046/j.1365-2036.2002.01190.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
277 LaBrecque DR. A commonsense approach to variceal bleeding. Clin Liver Dis 1997;1:121-7, xii. [PMID: 15562673 DOI: 10.1016/s1089-3261(05)70260-9] [Reference Citation Analysis]
278 Bosch J. Salvage transjugular intrahepatic portosystemic shunt: is it really life-saving? J Hepatol. 2001;35:658-660. [PMID: 11690713 DOI: 10.1016/s0168-8278(01)00238-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
279 Heller J, Sauerbruch T. Prevention of recurrent haemorrhage. Best Practice & Research Clinical Gastroenterology 2007;21:43-53. [DOI: 10.1016/j.bpg.2006.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
280 Uehara H, Kawanaka H, Nakanoko T, Sugiyama M, Ota M, Mano Y, Sugimachi K, Morita M, Toh Y. Successful hybrid surgery for ileal conduit stomal varices following oxaliplatin-based chemotherapy in a patient with advanced colorectal cancer. Surg Case Rep 2020;6:236. [PMID: 32990797 DOI: 10.1186/s40792-020-01021-6] [Reference Citation Analysis]
281 Bloom RD, Goldberg LR, Wang AY, Faust TW, Kotloff RM. An Overview of Solid Organ Transplantation. Clinics in Chest Medicine 2005;26:529-43. [DOI: 10.1016/j.ccm.2005.06.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
282 Grace JA, Herath CB, Mak KY, Burrell LM, Angus PW. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options. Clin Sci (Lond). 2012;123:225-239. [PMID: 22548407 DOI: 10.1042/cs20120030] [Cited by in Crossref: 55] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
283 Yang YY, Lin HC, Huang YT, Hou MC, Lee FY, Chang FY, Lee SD. Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen. J Hepatol. 2005;42:652-658. [PMID: 15826713 DOI: 10.1016/j.jhep.2004.11.044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
284 Seo YS. Prevention and management of gastroesophageal varices. Clin Mol Hepatol. 2018;24:20-42. [PMID: 29249128 DOI: 10.3350/cmh.2017.0064] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
285 Mosli MH, Aljudaibi B, Almadi M, Marotta P. The safety and efficacy of gastric fundal variceal obliteration using N-butyl-2-cyanoacrylate; the experience of a single canadian tertiary care centre. Saudi J Gastroenterol. 2013;19:152-159. [PMID: 23828744 DOI: 10.4103/1319-3767.114508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
286 Morales J, Moitinho E, Abraldes JG, Fernandez M, Bosch J. Effects of the V1a vasopressin agonist F-180 on portal hypertension-related bleeding in portal hypertensive rats. Hepatology;38:1378-83. [DOI: 10.1016/j.hep.2003.09.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
287 Iannitti DA, Henderson J. 9 Surgery in portal hypertension. Baillière's Clinical Gastroenterology 1997;11:351-64. [DOI: 10.1016/s0950-3528(97)90044-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
288 Li K, Neuberger J. The management of patients awaiting liver transplantation. Nat Rev Gastroenterol Hepatol 2009;6:648-59. [DOI: 10.1038/nrgastro.2009.163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
289 Perumalswami PV, Schiano TD. The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci 2011;56:1266-81. [PMID: 21416246 DOI: 10.1007/s10620-011-1619-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
290 Sarin SK, Wadhawan M, Gupta R, Shahi H. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. Dig Dis Sci. 2005;50:1538-1547. [PMID: 16110851 DOI: 10.1007/s10620-005-2877-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
291 Krige J, Jonas E, Kotze U, Kloppers C, Gandhi K, Allam H, Bernon M, Burmeister S, Setshedi M. Defining the advantages and exposing the limitations of endoscopic variceal ligation in controlling acute bleeding and achieving complete variceal eradication. World J Gastrointest Endosc 2020; 12(10): 365-377 [PMID: 33133373 DOI: 10.4253/wjge.v12.i10.365] [Reference Citation Analysis]
292 Gugig R, Rosenthal P. Management of portal hypertension in children. World J Gastroenterol 2012; 18(11): 1176-1184 [PMID: 22468080 DOI: 10.3748/wjg.v18.i11.1176] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
293 Garcia–tsao G. Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 2001;120:726-48. [DOI: 10.1053/gast.2001.22580] [Cited by in Crossref: 292] [Cited by in F6Publishing: 235] [Article Influence: 13.9] [Reference Citation Analysis]
294 García-Pagán JC, Morillas R, Bañares R, Albillos A, Villanueva C, Vila C, Genescà J, Jimenez M, Rodriguez M, Calleja JL, Balanzó J, García-Durán F, Planas R, Bosch J; Spanish Variceal Bleeding Study Group. Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT. Hepatology 2003;37:1260-6. [PMID: 12774003 DOI: 10.1053/jhep.2003.50211] [Cited by in Crossref: 121] [Cited by in F6Publishing: 84] [Article Influence: 6.4] [Reference Citation Analysis]
295 Kim SG, Kim TY, Sohn JH, Um SH, Seo YS, Baik SK, Kim MY, Jang JY, Jeong SW, Lee B. A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis. Am J Gastroenterol. 2016;111:1582-1590. [PMID: 27575713 DOI: 10.1038/ajg.2016.327] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
296 Patch D, Sabin CA, Goulis J, Gerunda G, Greenslade L, Merkel C, Burroughs AK. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002;123:1013-9. [PMID: 12360462 DOI: 10.1053/gast.2002.35955] [Cited by in Crossref: 175] [Cited by in F6Publishing: 128] [Article Influence: 8.8] [Reference Citation Analysis]
297 Gerbes AL, Gülberg V, Waggershauser T, Holl J, Reiser M. Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension: comparison of emergency and elective interventions. Dig Dis Sci. 1998;43:2463-2469. [PMID: 9824135 DOI: 10.1023/a:1026686232756] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
298 Kim SH, Kim YJ, Lee JM, Choi KD, Chung YJ, Han JK, Lee JY, Lee MW, Han CJ, Choi JI, Shin KS, Choi BI. Esophageal varices in patients with cirrhosis: multidetector CT esophagography--comparison with endoscopy. Radiology. 2007;242:759-768. [PMID: 17229872 DOI: 10.1148/radiol.2423050784] [Cited by in Crossref: 70] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
299 Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology 1999;30:79-83. [PMID: 10385642 DOI: 10.1002/hep.510300124] [Cited by in Crossref: 113] [Cited by in F6Publishing: 96] [Article Influence: 4.9] [Reference Citation Analysis]
300 Isfort P, Penzkofer T, Wilkmann C, Na HS, Kotzlowski C, Ito N, Pfeffer JG, Bisplinghoff S, Osterhues S, Besting A, Gooding J, Schmitz-Rode T, Kuhl C, Mahnken AH, Bruners P. Feasibility of electromagnetically guided transjugular intrahepatic portosystemic shunt procedure. Minim Invasive Ther Allied Technol 2017;26:15-22. [PMID: 27686414 DOI: 10.1080/13645706.2016.1214155] [Reference Citation Analysis]
301 McDiarmid SV. Liver transplantation. The pediatric challenge. Clin Liver Dis 2000;4:879-927. [PMID: 11232362 DOI: 10.1016/s1089-3261(05)70146-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
302 Hartigan PM, Gebhard RL, Gregory PB. Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis. Veterans Affairs Cooperative Variceal Sclerotherapy Group. Gastrointest Endosc. 1997;46:1-7. [PMID: 9260697 DOI: 10.1016/s0016-5107(97)70201-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
303 Kumar S, Asrani SK, Kamath PS. Epidemiology, diagnosis and early patient management of esophagogastric hemorrhage. Gastroenterol Clin North Am. 2014;43:765-782. [PMID: 25440924 DOI: 10.1016/j.gtc.2014.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
304 Thomsen BL, Sørensen TI. Analysis of the treatment effect on recurrent bleeding and death in patients with cirrhosis and esophageal varices. Journal of Hepatology 1998;28:107-14. [DOI: 10.1016/s0168-8278(98)80209-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
305 Yao HS, Wang WJ, Wang Q, Gao WC, Xiang HG, Hu ZQ, Gao JD, Chen XY, Wang WM. Randomized clinical trial of vessel sealing system (LigaSure) in esophagogastric devascularization and splenectomy in patients with portal hypertension. Am J Surg. 2011;202:82-90. [PMID: 21741519 DOI: 10.1016/j.amjsurg.2010.10.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
306 Vargas HE, Gerber D, Abu-Elmagd K. Management of portal hypertension-related bleeding. Surg Clin North Am 1999;79:1-22. [PMID: 10073179 DOI: 10.1016/s0039-6109(05)70004-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
307 Lowe RC, Grace ND. Primary prophylaxis of variceal hemorrhage. Clin Liver Dis. 2001;5:665-676. [PMID: 11565136 DOI: 10.1016/s1089-3261(05)70187-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
308 Younossi Z, Guyatt G. Evidence-based medicine: A method for solving clinical problems in hepatology. Hepatology 1999;30:829-32. [DOI: 10.1002/hep.510300408] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
309 Ioannou GN, Doust J, Rockey DC. Terlipressin in acute oesophageal variceal haemorrhage: TERLIPRESSIN AND OESOPHAGEAL VARICEAL HAEMORRHAGE. Alimentary Pharmacology & Therapeutics 2003;17:53-64. [DOI: 10.1046/j.1365-2036.2003.01356.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 81] [Article Influence: 5.8] [Reference Citation Analysis]
310 Garcia-Tsao G, Lim JK; Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802-1829. [PMID: 19455106 DOI: 10.1038/ajg.2009.191] [Cited by in Crossref: 168] [Cited by in F6Publishing: 146] [Article Influence: 12.9] [Reference Citation Analysis]
311 Anacréon S, Bischoff F, Frenkiel J, Beaujard E. [Cause of death in patients with cirrhosis]. Rev Med Interne 2001;22:926-33. [PMID: 11695315 DOI: 10.1016/s0248-8663(01)00450-7] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
312 Flemming JA, Saxena V, Shen H, Terrault NA, Rongey C. Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA. Dig Dis Sci. 2016;61:62-69. [PMID: 26363933 DOI: 10.1007/s10620-015-3865-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
313 Zhang L, Luo HP, Liu FL, Zhang WG. Prior Esophagogastric Devascularization Followed by Splenectomy for Liver Cirrhosis with Portal Hypertension: A Modified Laparoscopic Technique. Gastroenterol Res Pract 2019;2019:2623749. [PMID: 30863438 DOI: 10.1155/2019/2623749] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
314 Haq I, Tripathi D. Recent advances in the management of variceal bleeding. Gastroenterol Rep (Oxf)5:113-126. [PMID: 28533909 DOI: 10.1093/gastro/gox007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
315 Singal AK, Ahmad M, Soloway RD. Duplex Doppler ultrasound examination of the portal venous system: an emerging novel technique for the estimation of portal vein pressure. Dig Dis Sci. 2010;55:1230-1240. [PMID: 19629688 DOI: 10.1007/s10620-009-0887-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
316 Taegtmeyer AB, Haschke M, Tchambaz L, Buylaert M, Tschöpl M, Beuers U, Drewe J, Krähenbühl S. A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls. PLoS One 2014;9:e97885. [PMID: 24906133 DOI: 10.1371/journal.pone.0097885] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
317 Glowka TR, Kalff JC, Manekeller S. Update on Shunt Surgery. Visc Med 2020;36:206-11. [PMID: 32775351 DOI: 10.1159/000507125] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
318 Marrero RJ, Barkin JS. Wireless capsule endoscopy and portal hypertensive intestinal vasculopathy. Gastrointest Endosc. 2005;62:535-537. [PMID: 16185967 DOI: 10.1016/j.gie.2005.06.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
319 Luketic VA, Sanyal AJ. ESOPHAGEAL VARICES. Gastroenterology Clinics of North America 2000;29:387-421. [DOI: 10.1016/s0889-8553(05)70120-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
320 Maruyama H, Okugawa H, Yoshizumi H, Kobayashi S, Yokosuka O. Hemodynamic Features of Gastrorenal Shunt. Academic Radiology 2008;15:1148-54. [DOI: 10.1016/j.acra.2008.03.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
321 Rössle M. Prevention of rebleeding from oesophageal-gastric varices. Eur J Gastroenterol Hepatol. 2001;13:343-348. [PMID: 11338060 DOI: 10.1097/00042737-200104000-00007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
322 Bass NM. Role of TIPS in portal hypertension: variceal bleeding and ascites. Techniques in Vascular and Interventional Radiology 1998;1:44-50. [DOI: 10.1016/s1089-2516(98)80010-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
323 Patch D, Dagher L. Acute variceal bleeding: general management. World J Gastroenterol 2001; 7(4): 466-475 [PMID: 11819812 DOI: 10.3748/wjg.v7.i4.466] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
324 Karagiannakis DS, Papatheodoridis G, Vlachogiannakos J. Recent advances in cirrhotic cardiomyopathy. Dig Dis Sci. 2015;60:1141-1151. [PMID: 25404411 DOI: 10.1007/s10620-014-3432-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
325 Kodama H, Aikata H, Takaki S, Takahashi S, Toyota N, Ito K, Chayama K. Evaluation of patients with esophageal varices after endoscopic injection sclerotherapy using multiplanar reconstruction MDCT images. AJR Am J Roentgenol. 2009;192:122-130. [PMID: 19098190 DOI: 10.2214/ajr.08.1268] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
326 Ravipati M, Katragadda S, Swaminathan PD, Molnar J, Zarling E. Pharmacotherapy plus endoscopic intervention is more effective than pharmacotherapy or endoscopy alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized, controlled trials. Gastrointest Endosc 2009;70:658-664.e5. [PMID: 19643407 DOI: 10.1016/j.gie.2009.02.029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
327 Burton JR, Liangpunsakul S, Lapidus J, Giannini E, Chalasani N, Zaman A. Validation of a multivariate model predicting presence and size of varices. J Clin Gastroenterol. 2007;41:609-615. [PMID: 17577118 DOI: 10.1097/01.mcg.0000225669.84099.04] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
328 Aoyama T, Oka S, Aikata H, Nakano M, Watari I, Naeshiro N, Yoshida S, Tanaka S, Chayama K. Is small-bowel capsule endoscopy effective for diagnosis of esophagogastric lesions related to portal hypertension? J Gastroenterol Hepatol. 2014;29:511-516. [PMID: 23981241 DOI: 10.1111/jgh.12372] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
329 Nidegger D, Ragot S, Berthelémy P, Masliah C, Pilette C, Martin T, Bianchi A, Paupard T, Silvain C, Beauchant M. Cirrhosis and bleeding: the need for very early management. J Hepatol. 2003;39:509-514. [PMID: 12971959 DOI: 10.1016/s0168-8278(03)00322-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
330 Samonakis DN, Triantos CK, Thalheimer U, Patch DW, Burroughs AK. Management of portal hypertension. Postgrad Med J. 2004;80:634-641. [PMID: 15537846 DOI: 10.1136/pgmj.2004.020446] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
331 Pomier-Layrargues G, Villeneuve JP, Deschênes M, Bui B, Perreault P, Fenyves D, Willems B, Marleau D, Bilodeau M, Lafortune M, Dufresne MP. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001;48:390-6. [PMID: 11171831 DOI: 10.1136/gut.48.3.390] [Cited by in Crossref: 100] [Cited by in F6Publishing: 76] [Article Influence: 4.8] [Reference Citation Analysis]
332 Blendis L, Wong F. The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther. 2001;89:221-231. [PMID: 11516477 DOI: 10.1016/s0163-7258(01)00124-3] [Cited by in Crossref: 92] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
333 Aoki N, Kajiyama T, Beck J, Cone RW, Soma K, Fukui T. Decision analysis of prophylactic treatment for patients with high-risk esophageal varices. Gastrointestinal Endoscopy 2000;52:707-14. [DOI: 10.1067/mge.2000.110729] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
334 Heyman MB, Laberge JM. Role of Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension in Pediatric Patients: . Journal of Pediatric Gastroenterology & Nutrition 1999;29:240-9. [DOI: 10.1097/00005176-199909000-00004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
335 Kato T, Hikichi T, Nakamura J, Takasumi M, Hashimoto M, Kobashi R, Yanagita T, Takagi T, Suzuki R, Sugimoto M, Sato Y, Irie H, Okubo Y, Kobayakawa M, Ohira H. Usefulness of Endoscopic Ultrasound with the Jelly-Filling Method for Esophageal Varices. Diagnostics (Basel) 2021;11:1726. [PMID: 34574067 DOI: 10.3390/diagnostics11091726] [Reference Citation Analysis]
336 Yan BM, Lee SS. Emergency management of bleeding esophageal varices: drugs, bands or sleep? Can J Gastroenterol 2006;20:165-70. [PMID: 16550260 DOI: 10.1155/2006/743783] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
337 Opio CK, Garcia-tsao G. Managing Varices: Drugs, Bands, and Shunts. Gastroenterology Clinics of North America 2011;40:561-79. [DOI: 10.1016/j.gtc.2011.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
338 Fagundes EDT, Ferreira AR, Roquete MLV, Penna FJ, Goulart EMA, Filho PPF, Bittencourt PFS, Carvalho SD, Albuquerque W. Clinical and Laboratory Predictors of Esophageal Varices in Children and Adolescents With Portal Hypertension Syndrome. Journal of Pediatric Gastroenterology & Nutrition 2008;46:178-83. [DOI: 10.1097/mpg.0b013e318156ff07] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
339 Raines DL, Dupont AW, Arguedas MR. Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding. Aliment Pharmacol Ther 2004;19:571-81. [PMID: 14987326 DOI: 10.1111/j.1365-2036.2004.01875.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
340 Augustin S, González A, Genescà J. Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol 2010; 2(7): 261-274 [PMID: 21161008 DOI: 10.4254/wjh.v2.i7.261] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
341 Talwalkar JA, Kamath PS. Influence of Recent Advances in Medical Management on Clinical Outcomes of Cirrhosis. Mayo Clinic Proceedings 2005;80:1501-8. [DOI: 10.4065/80.11.1501] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
342 Yeh JL, Peng YC, Tung CF, Chen GH, Chow WK, Chang CS, Yeh HZ, Poon SK. Clinical predictors of large esophagogastric varices in patients with hepatocellular carcinoma. Dig Dis Sci. 2002;47:723-729. [PMID: 11991599 DOI: 10.1023/a:1014719428637] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
343 Malandris K, Paschos P, Katsoula A, Manolopoulos A, Andreadis P, Sarigianni M, Athanasiadou E, Akriviadis E, Tsapas A. Carvedilol for prevention of variceal bleeding: a systematic review and meta-analysis. Ann Gastroenterol 2019;32:287-97. [PMID: 31040627 DOI: 10.20524/aog.2019.0368] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
344 Bernadich C, Bandi J, Melin P, Bosch J. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Hepatology 1998;27:351-6. [DOI: 10.1002/hep.510270206] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 1.8] [Reference Citation Analysis]
345 Forrest E, Stanley A, Hayes P. Carvedilol?A new nonselective beta blocker. Hepatology 2000;31:809-11. [DOI: 10.1002/hep.510310341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
346 Kim DH, Park JY. Prevention and management of variceal hemorrhage. Int J Hepatol 2013;2013:434609. [PMID: 23606973 DOI: 10.1155/2013/434609] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
347 Park EJ, Jang JY, Lee JE, Jeong SW, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Cho JY, Kim HS, Kim BS, Kim YJ. The risk factors for bleeding of fundal varices in patients with liver cirrhosis. Gut Liver 2013;7:704-11. [PMID: 24312712 DOI: 10.5009/gnl.2013.7.6.704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
348 Khan F, Tripathi D. Role of early transjugular intrahepatic portosystemic stent-shunt in acute variceal bleeding: An update of the evidence and future directions. World J Gastroenterol 2021; 27(44): 7612-7624 [PMID: 34908802 DOI: 10.3748/wjg.v27.i44.7612] [Reference Citation Analysis]
349 Kawai T, Yashima Y, Sugimoto T, Sato T, Kanda M, Enomoto N, Sato S, Obi S. Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study. World J Surg Oncol 2016;14:52. [PMID: 26911980 DOI: 10.1186/s12957-016-0802-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
350 Villanueva C, Aracil C, López-Balaguer JM, Balanzó J. [Combined treatments for esophageal varices]. Gastroenterol Hepatol 2003;26:514-23. [PMID: 14534024 DOI: 10.1016/s0210-5705(03)70403-8] [Reference Citation Analysis]
351 Bañares R, Moitinho E, Matilla A, García-pagán JC, Lampreave JL, Piera C, Abraldes JG, De Diego A, Albillos A, Bosch J. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis: Randomized Comparison of Long-Term Carvedilol and Propranolol Administration in the Treatment of Portal Hypertension in Cirrhosis. Hepatology 2002;36:1367-73. [DOI: 10.1002/hep.1840360612] [Cited by in Crossref: 97] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
352 Sung JJ, Lee YT, Leong RW. EUS in portal hypertension. Gastrointestinal Endoscopy 2002;56:S35-43. [DOI: 10.1016/s0016-5107(02)70084-9] [Cited by in Crossref: 12] [Article Influence: 0.6] [Reference Citation Analysis]
353 Lin H, Huang Y, Wu H, Lee W, Hou M, Lee F, Chang F, Lee S. Effects of sustained-release lanreotide on hemodynamics in rats with portal vein stenosis. Journal of Hepatology 1999;31:482-8. [DOI: 10.1016/s0168-8278(99)80041-5] [Cited by in Crossref: 13] [Article Influence: 0.6] [Reference Citation Analysis]
354 Palaniappan SK, Than NN, Thein AW, van Mourik I. Interventions for preventing and managing advanced liver disease in cystic fibrosis. Cochrane Database Syst Rev 2020;3:CD012056. [PMID: 32227478 DOI: 10.1002/14651858.CD012056.pub3] [Reference Citation Analysis]
355 Pimenta JR, Ferreira AR, Fagundes EDT, Bittencourt PFS, Moura AM, Carvalho SD. Evaluation of endoscopic secondary prophylaxis in children and adolescents with esophageal varices. Arq Gastroenterol 2017;54:21-6. [DOI: 10.1590/s0004-2803.2017v54n1-04] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
356 Seo YS, Kim YH, Ahn SH, Yu SK, Baik SK, Choi SK, Heo J, Hahn T, Yoo TW, Cho SH. Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis. J Korean Med Sci. 2008;23:635-643. [PMID: 18756050 DOI: 10.3346/jkms.2008.23.4.635] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
357 Herath CB, Grace JA, Angus PW. Therapeutic potential of targeting the renin angiotensin system in portal hypertension. World J Gastrointest Pathophysiol 2013; 4(1): 1-11 [PMID: 23596549 DOI: 10.4291/wjgp.v4.i1.1] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
358 García-villarreal L, Martínez-lagares F, Sierra A, Guevara C, Marrero JM, Jiménez E, Monescillo A, Hernández-cabrero T, Alonso JM, Fuentes R. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage: Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Sclerotherapy for the Prevention of Variceal Rebleeding After Recent Variceal Hemorrha. Hepatology 1999;29:27-32. [DOI: 10.1002/hep.510290125] [Cited by in Crossref: 104] [Cited by in F6Publishing: 89] [Article Influence: 5.5] [Reference Citation Analysis]
359 Bosch J, García-pagán JC. Complications of cirrhosis. I. Portal hypertension. Journal of Hepatology 2000;32:141-56. [DOI: 10.1016/s0168-8278(00)80422-5] [Cited by in Crossref: 328] [Cited by in F6Publishing: 112] [Article Influence: 14.9] [Reference Citation Analysis]
360 Nagaoki Y, Aikata H, Kobayashi T, Fukuhara T, Masaki K, Tanaka M, Naeshiro N, Nakahara T, Honda Y, Miyaki D, Kawaoka T, Takaki S, Tsuge M, Hiramatsu A, Imamura M, Hyogo H, Kawakami Y, Takahashi S, Ochi H, Chayama K. Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosis. J Gastroenterol 2013;48:847-55. [PMID: 23053422 DOI: 10.1007/s00535-012-0679-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
361 Rajvanshi P, Kowdley KV. Prediction of varices in patients with cirrhosis: a high-stakes numbers game? J Clin Gastroenterol 2002;34:4-5. [PMID: 11743239 DOI: 10.1097/00004836-200201000-00003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
362 Chang F, Huang Y, Lin H, Hong C, Lin J, Chen K. Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats. Can J Physiol Pharmacol 1999;77:618-24. [DOI: 10.1139/y99-064] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
363 Iwao T, Oho K, Sakai T, Sato M, Nakano R, Yamawaki M, Toyonaga A, Tanikawa K. Upright posture decreases esophageal varices flow velocity in patients with cirrhosis. Journal of Hepatology 1998;28:447-53. [DOI: 10.1016/s0168-8278(98)80319-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
364 Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet. 1999;353:139-142. [PMID: 10023916 DOI: 10.1016/s0140-6736(98)06020-6] [Cited by in Crossref: 196] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
365 Thuluvath PJ, Krishnan A. Primary Prophylaxis of Variceal Bleeding. Gastrointestinal Endoscopy 2003;58:558-67. [DOI: 10.1067/s0016-5107(03)01971-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
366 Lee J, Huo T, Huang H, Lee F, Lin H, Chuang C, Chang C, Wang S, Lee S. Propranolol modulates the collateral vascular responsiveness to vasopressin via a Gα-mediated pathway in portal hypertensive rats. Clinical Science 2011;121:545-54. [DOI: 10.1042/cs20100590] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
367 Hayes PC. The use of endoscopic band ligation for the prophylaxis of variceal haemorrhage. J Hepatol 1999;31:561-2. [PMID: 10488720 DOI: 10.1016/s0168-8278(99)80053-1] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
368 Rössle M, Grandt D. TIPS: an update. Best Pract Res Clin Gastroenterol. 2004;18:99-123. [PMID: 15123087 DOI: 10.1016/j.bpg.2003.08.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
369 Alempijević T, Bulat V, Kovacević N, Jegić R, Duranović S, Tomić D, Krstić M. [Noninvasive assessment of oesophageal varices presence and size in patients with liver cirrhosis using right liver lobe/serum albumin concentration]. Vojnosanit Pregl 2007;64:453-7. [PMID: 17821919 DOI: 10.2298/vsp0707453a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
370 Luo HP, Zhang ZG, Long X, Liu FL, Chen XP, Zhang L, Zhang WG. Combined Laparoscopic Splenectomy and Esophagogastric Devascularization versus Open Splenectomy and Esophagogastric Devascularization for Portal Hypertension due to Liver Cirrhosis. Curr Med Sci 2020;40:117-22. [PMID: 32166673 DOI: 10.1007/s11596-020-2154-8] [Reference Citation Analysis]
371 van Buuren HR, Rasch MC, Batenburg PL, Bolwerk CJ, Nicolai JJ, van der Werf SD, Scherpenisse J, Arends LR, van Hattum J, Rauws EA. Endoscopic sclerotherapy compared with no specific treatment for the primary prevention of bleeding from esophageal varices. A randomized controlled multicentre trial [ISRCTN03215899]. BMC Gastroenterol. 2003;3:22. [PMID: 12919638 DOI: 10.1186/1471-230x-3-22] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
372 Wu C, Yeh H, Chen G. Pharmacologic Efficacy in Gastric Variceal Rebleeding and Survival: Including Multivariate Analysis. Journal of Clinical Gastroenterology 2002;35:127-32. [DOI: 10.1097/00004836-200208000-00002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
373 Sauerbruch T, Trebicka J. Future therapy of portal hypertension in liver cirrhosis - a guess. F1000Prime Rep. 2014;6:95. [PMID: 25374673 DOI: 10.12703/P6-95] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
374 Binmoeller KF, Sendino O, Kane SD. Endoscopic ultrasound-guided intravascular therapy. J Hepatobiliary Pancreat Sci 2015;22:44-50. [PMID: 25366271 DOI: 10.1002/jhbp.183] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
375 Norton ID, Andrews JC, Kamath PS. Management of ectopic varices. Hepatology. 1998;28:1154-1158. [PMID: 9755256 DOI: 10.1002/hep.510280434] [Cited by in Crossref: 215] [Cited by in F6Publishing: 176] [Article Influence: 9.0] [Reference Citation Analysis]
376 Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, Attili AF, Riggio O. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38:266-272. [PMID: 12586291 DOI: 10.1016/s0168-8278(02)00420-8] [Cited by in Crossref: 323] [Cited by in F6Publishing: 95] [Article Influence: 17.0] [Reference Citation Analysis]
377 Kim H, Choi D, Gwak GY, Lee JH, Park MK, Lee HIe, Kim SH, Nam S, Yoo EY, Do YS. Evaluation of esophageal varices on liver computed tomography: receiver operating characteristic analyses of the performance of radiologists and endoscopists. J Gastroenterol Hepatol. 2009;24:1534-1540. [PMID: 19486446 DOI: 10.1111/j.1440-1746.2009.05849.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
378 Luca A, D'Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology. 1999;212:411-421. [PMID: 10429698 DOI: 10.1148/radiology.212.2.r99au46411] [Cited by in Crossref: 146] [Cited by in F6Publishing: 123] [Article Influence: 6.3] [Reference Citation Analysis]
379 Avgerinos A, Armonis A, Stefanidis G, Mathou N, Vlachogiannakos J, Kougioumtzian A, Triantos C, Papaxoinis C, Manolakopoulos S, Panani A. Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology. 2004;39:1623-1630. [PMID: 15185303 DOI: 10.1002/hep.20236] [Cited by in Crossref: 97] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
380 Gurghean AV, Tudor IA. Pulmonary hypertension in patients with hepatic cirrhosis and portal hypertension. An echographic study. Clujul Med 2017;90:161-5. [PMID: 28559699 DOI: 10.15386/cjmed-705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
381 Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology. 2008;134:1715-1728. [PMID: 18471549 DOI: 10.1053/j.gastro.2008.03.007] [Cited by in Crossref: 215] [Cited by in F6Publishing: 174] [Article Influence: 15.4] [Reference Citation Analysis]
382 Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Journal of Hepatology 1997;26:312-24. [DOI: 10.1016/s0168-8278(97)80047-5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
383 Schoenfeld PS, Butler JA. AN EVIDENCE-BASED APPROACH TO THE TREATMENT OF ESOPHAGEAL VARICEAL BLEEDING. Critical Care Clinics 1998;14:441-55. [DOI: 10.1016/s0749-0704(05)70010-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
384 Ferguson JW, Tripathi D, Hayes PC. Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther. 2003;18:253-262. [PMID: 12895210 DOI: 10.1046/j.1365-2036.2003.01664.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
385 Kim SJ, Choi CW, Kang DH, Kim HW, Park SB, Hong YM, Yoon KT, Cho M, Nam HS, Islam SB. Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding. Clin Mol Hepatol 2016;22:466-76. [PMID: 28081590 DOI: 10.3350/cmh.2016.0063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
386 Stanley AJ, Hayes PC. Portal hypertension and variceal haemorrhage. Lancet. 1997;350:1235-1239. [PMID: 9652580 DOI: 10.1016/S0140-6736(97)06283-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
387 Avgerinos A, Viazis N, Armonis A, Vlachogiannakos J, Rekoumis G, Stefanidis G, Papadimitriou N, Manolakopoulos S, Raptis SA. Early increase of lower oesophageal sphincter pressure after band ligation of oesophageal varices in cirrhotics: an intriguing phenomenon. Eur J Gastroenterol Hepatol 2002;14:1319-23. [PMID: 12468952 DOI: 10.1097/00042737-200212000-00006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
388 Faigel DO, Rosen HR, Sasaki A, Flora K, Benner K. EUS in cirrhotic patients with and without prior variceal hemorrhage in comparison with noncirrhotic control subjects. Gastrointest Endosc 2000;52:455-62. [PMID: 11023560 DOI: 10.1067/mge.2000.107297] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
389 Khan K, Schwarzenberg SJ, Sharp HL, Matas AJ, Chavers BM. Morbidity from congenital hepatic fibrosis after renal transplantation for autosomal recessive polycystic kidney disease. Am J Transplant. 2002;2:360-365. [PMID: 12118859 DOI: 10.1034/j.1600-6143.2002.20412.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
390 Strauss E, Sakai P, Gayotto LCDC, Cardoso RA, Forster S, Raia S. Size of gastroesophageal varices: its behavior after the surgical treatment of portal hypertension. Rev Hosp Clin 1999;54:193-8. [DOI: 10.1590/s0041-87811999000600005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
391 Hou MC, Lin HC, Kuo BI, Liao TM, Lee FY, Chang FY, Lee SD. Sequential variceal pressure measurement by endoscopic needle puncture during maintenance sclerotherapy: the correlation between variceal pressure and variceal rebleeding. J Hepatol. 1998;29:772-778. [PMID: 9833915 DOI: 10.1016/s0168-8278(98)80258-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
392 Garg PK, Joshi YK, Tandon RK. Comparison of endoscopic variceal sclerotherapy with sequential endoscopic band ligation plus low-dose sclerotherapy for secondary prophylaxis of variceal hemorrhage: a prospective randomized study. Gastrointest Endosc. 1999;50:369-373. [PMID: 10462658 DOI: 10.1053/ge.1999.v50.98594] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
393 Zhang Y, Zhang L, Wang M, Luo X, Wang Z, Wang G, Guo X, Wei F, Zhang Y. Selective Esophagogastric Devascularization in the Modified Sugiura Procedure for Patients with Cirrhotic Hemorrhagic Portal Hypertension: A Randomized Controlled Trial. Can J Gastroenterol Hepatol 2020;2020:8839098. [PMID: 33354559 DOI: 10.1155/2020/8839098] [Reference Citation Analysis]
394 Orloff MJ. Portal Hypertension and Portacaval Shunt**Supported by NIH Grants A3048, A5919, AM07315, AM07511, AM1228, AM19875, AM12280, AM17103, and DK41920. Surgical Research. Elsevier; 2001. pp. 637-701. [DOI: 10.1016/b978-012655330-7/50051-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
395 Talwalkar JA, Kamath PS. An evidence-based medicine approach to beta-blocker therapy in patients with cirrhosis. Am J Med. 2004;116:759-766. [PMID: 15144913 DOI: 10.1016/j.amjmed.2004.03.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
396 Hayes PC, Redhead DN, Finlayson ND. TIPSSing the scales for patients with cirrhosis. Scott Med J 2001;46:131-3. [PMID: 11771490 DOI: 10.1177/003693300104600501] [Reference Citation Analysis]
397 Tacke F, Fiedler K, Trautwein C. A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease. Scand J Gastroenterol. 2007;42:374-382. [PMID: 17354118 DOI: 10.1080/00365520600930826] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
398 Choi MH, Kim YS, Kim SG, Lee YN, Seo YR, Kim MJ, Lee SH, Jeong SW, Jang JY, Kim HS, Kim BS. The secondary prophylactic efficacy of beta-blocker after endoscopic gastric variceal obturation for first acute episode of gastric variceal bleeding. Clin Mol Hepatol 2013;19:280-7. [PMID: 24133666 DOI: 10.3350/cmh.2013.19.3.280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
399 Abraldes JG, Bureau C, Stefanescu H, Augustin S, Ney M, Blasco H, Procopet B, Bosch J, Genesca J, Berzigotti A; for the Anticipate Investigators. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study: Hepatology, Vol. XX, No. X, 2016 Abraldes et al. Hepatology 2016;64:2173-84. [DOI: 10.1002/hep.28824] [Cited by in Crossref: 115] [Cited by in F6Publishing: 100] [Article Influence: 19.2] [Reference Citation Analysis]
400 Biecker E. Portal hypertension and gastrointestinal bleeding: Diagnosis, prevention and management. World J Gastroenterol 2013; 19(31): 5035-5050 [PMID: 23964137 DOI: 10.3748/wjg.v19.i31.5035] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
401 De Franchis R, Primignani M. 6 Endoscopic treatments for portal hypertension. Baillière's Clinical Gastroenterology 1997;11:289-309. [DOI: 10.1016/s0950-3528(97)90041-5] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
402 Colombato L. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. J Clin Gastroenterol. 2007;41 Suppl 3:S344-S351. [PMID: 17975487 DOI: 10.1097/mcg.0b013e318157e500] [Cited by in Crossref: 90] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
403 Minor MA, Grace ND. Pharmacologic therapy of portal hypertension. Clin Liver Dis. 2006;10:563-581. [PMID: 17162228 DOI: 10.1016/j.cld.2006.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
404 Glowka TR, Kalff JC, Schäfer N. Clinical Management of Chronic Portal/Mesenteric Vein Thrombosis: The Surgeon’s Point of View. Viszeralmedizin. 2014;30:409-415. [PMID: 26288608 DOI: 10.1159/000369575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
405 Blendis L, Wong F. Blocking the bleeding way. Gastroenterology 1998;115:230-2. [DOI: 10.1016/s0016-5085(98)70389-0] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
406 Hou MC, Lin HC, Kuo BI, Liao TM, Lee FY, Chang FY, Lee SD. Sequential variceal pressure measurement by endoscopic needle puncture during maintenance sclerotherapy: the correlation between variceal pressure and variceal rebleeding. J Hepatol. 1998;29:772-778. [PMID: 9833915 DOI: org/10.1016/S0168-8278(98)80258-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
407 . Therapeutic Upper Endoscopy. In: Cotton PB, Williams CB, editors. Practical Gastrointestinal Endoscopy. Wiley; 2003. pp. 59-82. [DOI: 10.1002/9780470987032.ch5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
408 Triantos C, Kalafateli M. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis. World J Hepatol 2014; 6(6): 363-369 [PMID: 25018847 DOI: 10.4254/wjh.v6.i6.363] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
409 Dib N, Oberti F, Calès P. Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ 2006;174:1433-43. [PMID: 16682712 DOI: 10.1503/cmaj.051700] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
410 Lee FY, Chu CJ, Wang SS, Chang FY, Lin HC, Hou MC, Chan CC, Wu SL, Chen CT, Huang HC. Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hyposensitivity to glypressin in haemorrhage-transfused common bile duct-ligated rats. Eur J Clin Invest. 2001;31:145-153. [PMID: 11168453 DOI: 10.1046/j.1365-2362.2001.00764.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
411 Buscaglia JM, Dray X, Shin EJ, Magno P, Chmura KM, Surti VC, Dillon TE, Ducharme RW, Donatelli G, Thuluvath PJ. A new alternative for a transjugular intrahepatic portosystemic shunt: EUS-guided creation of an intrahepatic portosystemic shunt (with video). Gastrointest Endosc. 2009;69:941-947. [PMID: 19327481 DOI: 10.1016/j.gie.2008.09.051] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
412 Bosch J. A la carte or menu fixe: Improving pharmacologic therapy of portal hypertension: A La Carte or Menu Fixe: Improving Pharmacologic Therapy of Portal Hypertension. Hepatology 2002;36:1330-2. [DOI: 10.1002/hep.1840360606] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
413 Fierz FC, Kistler W, Stenz V, Gubler C. Treatment of esophageal variceal hemorrhage with self-expanding metal stents as a rescue maneuver in a swiss multicentric cohort. Case Rep Gastroenterol. 2013;7:97-105. [PMID: 23626509 DOI: 10.1159/000350192] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
414 White CM, Kilgore ML. PillCam ESO versus esophagogastro duodenoscopy in esophageal variceal screening: A decision analysis.J Clin Gastroenterol. 2009;43:975-981. [PMID: 19661814 DOI: 10.1097/MCG.0b013e3181a7ed09] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
415 Faust TW, Sorrell MF. THE ROLE OF THE TRANSJUGULAR INTRAHEPATIC PORTAL-SYSTEMIC SHUNT IN THE MANAGEMENT OF VARICEAL BLEEDING. Clinics in Liver Disease 1997;1:85-98. [DOI: 10.1016/s1089-3261(05)70257-9] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
416 Lo GH, Chen WC, Chan HH, Tsai WL, Hsu PI, Lin CK, Chen TA, Lai KH. A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding. J Gastroenterol Hepatol 2009;24:982-7. [PMID: 19638080 DOI: 10.1111/j.1440-1746.2009.05792.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
417 Barbu LA, Mărgăritescu ND, Şurlin MV. Diagnosis and Treatment Algorithms of Acute Variceal Bleeding. Curr Health Sci J 2017;43:191-200. [PMID: 30595875 DOI: 10.12865/CHSJ.43.03.02] [Reference Citation Analysis]
418 Rajoriya N, Tripathi D. Historical overview and review of current day treatment in the management of acute variceal haemorrhage. World J Gastroenterol 2014; 20(21): 6481-6494 [PMID: 24914369 DOI: 10.3748/wjg.v20.i21.6481] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
419 Gournay J, Masliah C, Martin T, Perrin D, Galmiche JP. Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding. Hepatology. 2000;31:1239-1245. [PMID: 10827148 DOI: 10.1053/jhep.2000.8106] [Cited by in Crossref: 127] [Cited by in F6Publishing: 90] [Article Influence: 5.8] [Reference Citation Analysis]
420 Gunnarsdottir SA, Olsson R, Björnsson ES. Characteristics, prognosis and outcome of patients with oesophageal varices in a university hospital in Sweden 1994-1999. Scand J Gastroenterol. 2005;40:1462-1468. [PMID: 16293558 DOI: 10.1080/00365520510023783] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
421 Mihas AA, Sanyal AJ. Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology 2004;127:621-9. [DOI: 10.1053/j.gastro.2004.05.060] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
422 Laubham M, Kallwitz E. Coagulation in chronic liver disease and the use of prothrombin complex concentrate for an emergent procedure: a case report and review of literature. J Community Hosp Intern Med Perspect 2018;8:138-41. [PMID: 29915653 DOI: 10.1080/20009666.2018.1466600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
423 Habib A, Bond WM, Heuman DM. Long-term management of cirrhosis: Appropriate supportive care is both critical and difficult. Postgraduate Medicine 2015;109:101-13. [DOI: 10.3810/pgm.2001.03.878] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
424 Boyer TD, Henderson JM, Heerey AM, Arrigain S, Konig V, Connor J, Abu-Elmagd K, Galloway J, Rikkers LF, Jeffers L; DIVERT Study Group. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol 2008;48:407-14. [PMID: 18045724 DOI: 10.1016/j.jhep.2007.08.014] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
425 Cremers I, Ribeiro S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol. 2014;7:206-216. [PMID: 25177367 DOI: 10.1177/1756283x14538688] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
426 de la Peña J, Brullet E, Sanchez-hernández E, Rivero M, Vergara M, Martin-lorente JL, Garcia Suárez C. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: A multicenter trial. Hepatology 2005;41:572-8. [DOI: 10.1002/hep.20584] [Cited by in Crossref: 150] [Cited by in F6Publishing: 116] [Article Influence: 8.8] [Reference Citation Analysis]
427 Alempijevic T, Bulat V, Djuranovic S, Kovacevic N, Jesic R, Tomic D, Krstic S, Krstic M. Right liver lobe/albumin ratio: Contribution to non-invasive assessment of portal hypertension. World J Gastroenterol 2007; 13(40): 5331-5335 [PMID: 17879402 DOI: 10.3748/wjg.v13.i40.5331] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
428 Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology. 1999;30:612-622. [PMID: 10462365 DOI: 10.1002/hep.510300316] [Cited by in Crossref: 218] [Cited by in F6Publishing: 171] [Article Influence: 9.5] [Reference Citation Analysis]
429 Chen WC, Hou MC, Lin HC, Lee FY, Yeh YY, Chang FY, Lee SD. Feasibility and potential benefit of maintenance endoscopic variceal ligation in patients with unresectable hepatocellular carcinoma and acute esophageal variceal hemorrhage: a controlled trial. Gastrointest Endosc. 2001;54:18-23. [PMID: 11427836 DOI: 10.1067/mge.2001.115731] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
430 Stein C, Korula J. Variceal bleeding: What are the treatment options? Postgraduate Medicine 2017;98:143-52. [DOI: 10.1080/00325481.1995.11946091] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
431 Slosberg EA, Keeffe EB. Sclerotherapy versus banding in the treatment of variceal bleeding. Clin Liver Dis 1997;1:77-84, xi. [PMID: 15562669 DOI: 10.1016/s1089-3261(05)70256-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
432 Schepke M, Sauerbruch T. Transjugular portosystemic stent shunt in treatment of liver diseases. World J Gastroenterol 2001; 7(2): 170-174 [PMID: 11819756 DOI: 10.3748/wjg.v7.i2.170] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
433 Fernandez-Urien I, Carretero C, Armendariz R, Muñoz-Navas M. Esophageal capsule endoscopy. World J Gastroenterol 2008; 14(34): 5254-5260 [PMID: 18785275 DOI: 10.3748/wjg.14.5254] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
434 Bhutta AQ, Garcia-Tsao G. The Role of Medical Therapy for Variceal Bleeding. Gastrointest Endosc Clin N Am 2015;25:479-90. [PMID: 26142033 DOI: 10.1016/j.giec.2015.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
435 Huang Y, Lin H, Tsai J, Hou M, Lee S, Hong C. Vascular hyporeactivity persists despite increased contractility after long-term administration of isosorbide dinitrate in portal hypertensive rats. Journal of Hepatology 1998;28:1037-44. [DOI: 10.1016/s0168-8278(98)80354-1] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
436 Ozaki M, Jogo A, Yamamoto A, Kaminou T, Hamuro M, Sohgawa E, Kageyama K, Ogawa S, Murai K, Nota T, Yonezawa H, Miki Y. Transcatheter embolization for stomal varices: A report of three patients. Radiol Case Rep 2021;16:801-6. [PMID: 33552329 DOI: 10.1016/j.radcr.2021.01.020] [Reference Citation Analysis]
437 Dell'Era A, de Franchis R, Iannuzzi F. Acute variceal bleeding: pharmacological treatment and primary/secondary prophylaxis. Best Pract Res Clin Gastroenterol. 2008;22:279-294. [PMID: 18346684 DOI: 10.1016/j.bpg.2007.11.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
438 Maddur H, Naik S, Siddiqui AA, Rockey DC. Adherence and adequacy of therapy for esophageal varices prophylaxis. Dig Dis Sci 2011;56:3129-36. [PMID: 21614592 DOI: 10.1007/s10620-011-1749-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
439 Rössle M, Deibert P, Haag K, Ochs A, Olschewski M, Siegerstetter V, Hauenstein KH, Geiger R, Stiepak C, Keller W. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet. 1997;349:1043-1049. [PMID: 9107241 DOI: 10.1016/s0140-6736(96)08189-5] [Cited by in Crossref: 172] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
440 Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1998;27:1207-1212. [PMID: 9581672 DOI: 10.1002/hep.510270504] [Cited by in Crossref: 303] [Cited by in F6Publishing: 217] [Article Influence: 12.6] [Reference Citation Analysis]
441 Schoenfeld P, Cook D, Hamilton F, Laine L, Morgan D, Peterson W. An evidence-based approach to gastroenterology therapy. Evidence-Based Gastroenterology Steering Group. Gastroenterology 1998;114:1318-25. [PMID: 9609770 DOI: 10.1016/s0016-5085(98)70439-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
442 Frossard JL, Seirafi M, Spahr L. Ectopic varices and collaterals development after band ligation treatment in a patient with portal hypertension. Case Rep Gastroenterol 2008;2:380-3. [PMID: 21490873 DOI: 10.1159/000155148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
443 Jamal MM, Samarasena JB, Hashemzadeh M, Vega KJ. Declining hospitalization rate of esophageal variceal bleeding in the United States. Clin Gastroenterol Hepatol. 2008;6:689-95; quiz 605. [PMID: 18456566 DOI: 10.1016/j.cgh.2008.02.049] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
444 Schreiber RA. Propranolol and Portal Hypertension: Should Kids Be on the Block?: . Journal of Pediatric Gastroenterology & Nutrition 1999;29:10-1. [DOI: 10.1097/00005176-199907000-00006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
445 Triantos C, Goulis J, Burroughs AK. Portal Hypertensive Bleeding. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 562-602. [DOI: 10.1002/9781444314403.ch36] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
446 Sass DA, Chopra KB. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2009;93:837-853, vii-viii. [PMID: 19577117 DOI: 10.1016/j.mcna.2009.03.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
447 Escorsell A, Bordas JM, Castañeda B, Llach J, García-Pagán JC, Rodés J, Bosch J. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Hepatology 2000;31:1061-7. [PMID: 10796880 DOI: 10.1053/he.2000.6779] [Cited by in Crossref: 121] [Cited by in F6Publishing: 93] [Article Influence: 5.5] [Reference Citation Analysis]
448 Garcı́a-pagán JC, Bosch J. Medical treatment of portal hypertension. Best Practice & Research Clinical Gastroenterology 2000;14:895-909. [DOI: 10.1053/bega.2000.0137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
449 Mileti E, Rosenthal P. Management of portal hypertension in children. Curr Gastroenterol Rep. 2011;13:10-16. [PMID: 20927620 DOI: 10.1007/s11894-010-0151-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
450 Oberti F, Veal N, Kaassis M, Pilette C, Rifflet H, Trouvé R, Calès P. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats. J Hepatol. 1998;29:103-111. [PMID: 9696498 DOI: 10.1016/s0168-8278(98)80184-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
451 Henderson JM. SALVAGE THERAPIES FOR REFRACTORY VARICEAL HEMORRHAGE. Clinics in Liver Disease 2001;5:709-25. [DOI: 10.1016/s1089-3261(05)70189-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
452 Thiele M, Krag A, Rohde U, Gluud LL. Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices. Aliment Pharmacol Ther. 2012;35:1155-1165. [PMID: 22449261 DOI: 10.1111/j.1365-2036.2012.05074.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 5.7] [Reference Citation Analysis]
453 Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, Lesmana LA, Guha Mazumder D, Omata M, Qureshi H, Raza RM, Sahni P, Sakhuja P, Salih M, Santra A, Sharma BC, Sharma P, Shiha G, Sollano J; Members of the APASL Working Party on Portal Hypertension. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int 2007;1:398-413. [PMID: 19669336 DOI: 10.1007/s12072-007-9010-9] [Cited by in Crossref: 105] [Cited by in F6Publishing: 84] [Article Influence: 7.0] [Reference Citation Analysis]
454 Frassei JDS, Franco CS, Brambilla VR, Loureiro BMC, Kiebert CDS, Fonseca EKUN, Ando SM, Sawamura MVY. Cyanoacrylate pulmonary embolism after endoscopic sclerotherapy of gastric varices. Einstein (Sao Paulo) 2021;19:eAI5778. [PMID: 33503148 DOI: 10.31744/einstein_journal/2021AI5778] [Reference Citation Analysis]
455 Hwang SS, Kim HH, Park SH, Kim SE, Jung JI, Ahn BY, Kim SH, Chung SK, Park YH, Choi KH. N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding. J Comput Assist Tomogr. 2001;25:16-22. [PMID: 11176287 DOI: 10.1097/00004728-200101000-00003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 3.9] [Reference Citation Analysis]
456 Henderson JM, Barnes DS, Geisinger MA. Portal hypertension. Current Problems in Surgery 1998;35:383-452. [DOI: 10.1016/s0011-3840(98)80030-0] [Cited by in Crossref: 24] [Article Influence: 1.0] [Reference Citation Analysis]
457 Han SW, Joo YE, Kim HS, Choi SK, Rew JS, Kim JK, Kim SJ. Clinical results of the transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of variceal bleeding. Korean J Intern Med. 2000;15:179-186. [PMID: 11242805 DOI: 10.3904/kjim.2000.15.3.179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]